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Leptin is secreted by the adipose tissue in proportion to fat stores and acts on 
the hypothalamus to inhibit appetite and promote energy expenditure.  Leptin also 
regulates glucose homeostasis independently of feeding, and has a permissive action on 
reproduction.  Activation of the leptin receptor (LepRb) initiates a cascade of signaling 
events, including the phosphorylation of residues on the intracellular domain of LepRb: 
Tyr985, Tyr1077 and Tyr1138.  The ongoing analysis of LepRb signaling mutants in vivo has 
revealed a crucial role for Tyr1138 in energy homeostasis, while Tyr985 appears to be 
important for the attenuation of LepRb signaling.  However, a number of the molecular 
mechanisms by which LepRb controls other physiological events, including neuronal 
firing, reproduction and glucose homeostasis, remain poorly defined.  Also unclear are 
the mechanisms that control leptin regulation of a variety of signals including mTORC1.  
In this study, we examined the regulation of the mTORC1 pathway in the basomedial 
hypothalamus, and investigated the specific role of LepRb-Tyr1077 in leptin action in vivo.  
We found that leptin does not modulate hypothalamic mTORC1 in a uniform manner, 
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but rather controls mTORC1 in opposite directions, in different cell types and brain 
regions.  Indeed, neuronal activation is the main regulator of mTORC1 activity in the 
hypothalamus in response to metabolic perturbations.  We also examined the 
phenotype of mice mutant for LepRb-Tyr1077 on a normal chow and a high fat diet.  
LepRbf1077/f1077 (f/f) mice had modestly increased body weight and food intake on both 
diets.  Both, male and female f/f mice had increased adiposity, and mutant females 
presented larger pancreas and ovaries than controls.  Interestingly, we found that 
LepRb-Tyr1077 seems to be mostly important for the regulation of reproduction and 
glucose homeostasis given that f/f female mice have delayed or absent estrous cycling 
together with improved glucose clearance.  These results suggest novel pathways by 
which leptin regulates neuronal firing, reproduction and glycemic control.  This 
information not only extends our understanding of leptin action, but could be crucial as 
we seek to understand the basis of conditions linking metabolism to reproduction and 





PUTTING IT ALL TOGETHER: OBESITY, LEPTIN-DEPENDENT SIGNALING PATHWAYS                        




The evolution of the obesity epidemic 
Throughout the years, scientists have proposed different theories in an attempt 
to explain the physiological systems that regulate body weight and energy balance.  
Theories ranging from circulating signals that control appetite to specific genetic and 
environmental factors (1) were proposed, and altogether, these concepts opened a 
whole new era of research in the energy homeostasis area.  Kennedy and colleagues (2) 
proposed the concept of a hypothalamic signal aimed to influence appetite and body fat 
stores in a coordinated manner.  Overall, understanding the mechanisms of body weight 
regulation is important because as food becomes widely available in developed 
countries, excessive energy storage becomes a huge problem as obesity develops.   
Obesity is a medical condition where an individual accumulates excess body fat 
and has increased body weight or a body mass index of 30.0 kg/m2 or greater, to the 
extent that it can increase the risk for a variety of diseases (including Type-II diabetes, 
cardiovascular disease and cancers).  Obesity affects more than 30% of the population in 
the United States, and its prevalence continues to increase despite all efforts to oppose 
it (3-5).  At its most basic level, obesity develops when energy intake exceeds energy 
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utilization.  The aggregate actions of a variety of hormones modulate energy 
expenditure, resulting in relatively little change in body weight or adiposity over time.   
Complex hormonal interactions in the periphery are crucial to maintain 
homeostasis of diverse physiological functions and feedback from these interactions is 
ultimately integrated at the level of the central nervous system (CNS) to control energy 
balance.  Of the hormones responsible for orchestrating energy homeostasis, the 
pancreatic β-cell-derived hormone insulin is a short-term signal secreted in proportion 
to meal size and is known to bind to its hypothalamic receptor (insulin receptor) to 
inhibit food intake (6-8).  In the periphery, insulin is a potent anabolic hormone essential 
for maintenance of whole-body glucose homeostasis by reducing hepatic glucose output 
and increasing glucose uptake, primarily into muscle and adipose tissue (9).  
On the other hand, ghrelin is a recently discovered orexigenic hormone secreted 
from the stomach (10;11).  Ghrelin stimulates the release of growth hormone (which 
among many important functions induces lipolysis) and it is elevated during fasting.  This 
hormone is known to bind to a hypothalamic ghrelin receptor to induce food intake and 
increase body weight gain (12;13).  While insulin and ghrelin play important roles, they 
are not the most important central regulators of feeding because deletion of insulin 
receptor in the CNS only causes mild obesity (14-16) and whole body deletion of ghrelin 
or the ghrelin receptor has a minimal energy homeostasis phenotype in mice (17-19).  
Thus, there must be another signal(s) responsible for the overall regulation of feeding 
and energy balance.   
The anorectic hormone, leptin 
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Mice homozygous for a spontaneous mutation in the obese (ob) gene (ob/ob 
mice) or the diabetes (db) gene (db/db mice) rapidly gain weight and reach three times 
the normal weight of wild-type controls at a young age.  These mice exhibit 
hyperphagia, hyperglycemia, hypercortisolemia, glucose intolerance, and insulin 
resistance.  These mutations also lead to an impaired immune system, infertility and 
increased metabolic efficiency (20-22).  By performing parabiosis studies in which the 
blood supply of ob/ob and db/db mice were joined to a wild-type mouse by vascular 
anastomosis, Coleman (23) found that ob/ob mice lacked the production of a circulating 
signal that induced anorexia, and that db/db mice lacked the response (presumably the 
receptor) to this signal.  Twenty years later, Zhang and colleagues cloned the ob gene 
and discovered its product, leptin (24).  Leptin is a 16 kD protein secreted by the adipose 
tissue in proportion to fat (energy) stores that inhibits appetite and promotes energy 
utilization.  Soon after the discovery of the obese (ob) gene, the leptin receptor was 
cloned and shown to be identical with the diabetes gene (db) (21).  Transcription of the 
leptin gene (ob) in mice yields an mRNA of ~3.5 kb that is expressed primarily in white 
adipose tissue (WAT), although is evident that it is produced in other tissues as well (25-
27).  In humans, leptin is encoded by a gene located in 7q31.3 and it is translated as a 
167 amino acid protein containing an amino-terminal secretory signal of 21 amino acids 
that is later removed at the microsomes, and thus leptin circulates in the blood as a 
protein of 146 amino acid residues (24).  Leptin is an interleukin-type-6 cytokine that is 
produced in levels roughly proportional to body fat stores.  Thus, leptin is well 
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positioned to communicate the amount of fat stores and consequently promote 
physiological processes that depend on energy availability.    
Physiological actions controlled by leptin  
Of the hormones controlling energy balance, leptin plays a central role (22;28-
30).  Lack of leptin signaling in mice and humans that are genetically null for either 
leptin (ob/ob mice) or for the leptin receptor (LepRb) (db/db mice) results in obesity 
secondary to increased feeding and decreased energy utilization (28;31-33).  These mice 
display a phenotype that resembles the neuroendocrine starvation response (i.e., 
hypothyroidism, decreased growth, infertility and decreased immune function) and 
exogenous leptin replacement restores each of these functions while decreasing 
appetite (34).  Leptin signaling similarly regulates the autonomic nervous system and 
the immune system (34;35) (Figure 1.1).  The lack of leptin does not underlie common 
forms of obesity, however, as leptin levels are generally elevated in proportion to 
adipose mass; the failure of high circulating leptin levels in obese states to promote 
weight loss defines a state of so-called “leptin resistance” (36-38).  Several potential 
mechanisms have been proposed to underlie leptin resistance, including defects in 
leptin access to the brain, leptin receptor signaling pathways or neurons that mediate 
downstream leptin action (39) but the etiology of this phenomenon still remains poorly 
defined.    
While adiposity greatly influences insulin sensitivity and glycemic control, leptin 
also regulates glucose homeostasis independently of feeding and energy balance (40) 
given that ob/ob and db/db mice  have impaired glycemic control that cannot be 
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reversed by fasting or pair feeding (41).  Also, in humans and rodent models of 
lipodystrophy, leptin treatment improves insulin sensitivity and diabetes prior to 
changes in energy balance (42-46).  These effects on glucose homeostasis appear to be 
mediated specifically by leptin in the CNS (47-49).  Furthermore, incubation of primary 
islet cultures with leptin results in suppression of insulin secretion (50) which suggests 
that leptin may also regulate glucose homeostasis via insulin production in the 
pancreatic β-cells (51).   
Leptin, energy stores and reproduction 
The “critical weight hypothesis” (52) states that there is a threshold level of body 
fat required in order for females to achieve menarche and maintain normal ovulatory 
cycles.  In normal women, a 10-15% decrease in body weight interrupts ovulation and 
menstrual cycle due to decreased secretion of gonadotropin releasing hormone (GnRH) 
by the hypothalamus (53;54).  Leptin has proven to play an important role in 
reproductive physiology given that leptin-deficient ob/ob mice are sterile but leptin 
administration increases ovary weight and corrects sterility in both male and female 
mice (55).  Prepubertal female mice injected with leptin experienced accelerated 
reproductive maturation demonstrated by the classical pubertal signs like vaginal 
opening, estrous and cycling (56;57).  Thus, adequate leptin levels enable the onset of 
reproductive competence and lack of leptin in rodents and humans with genetic leptin 
deficiency or lipodystrophy results in hypothalamic amenorrhea, which is reversible with 
leptin replacement (43;44).  Moreover, food restriction (which decreases leptin levels) 
and inadequate body fat levels, disrupts the activity of the reproductive axis, but leptin 
6 
 
treatment reverses this effect by partially restoring testosterone in male mice and 
luteinizing hormone (LH) levels and cyclicity in female mice (34;58).  Additionally, leptin 
treatment preserves LH pulse frequency, sexual maturation, ovulation and sexual 
behaviors in rodent models (59;60).  
Leptin receptors  
Leptin acts through a cell-surface receptor (LepRb) that is a member of the type I 
cytokine receptor family (61).  The mouse and human leptin receptor are highly similar 
in amino acid sequence for both the extracellular and intracellular domains (61).  The 
lepr gene contains 17 common exons and several alternatively spliced exons.  
Alternative splicing of the transcript from a single lepr gene and/or proteolytic 
processing of the subsequent protein product produces multiple LepR isoforms (62;63) 
and in mice, the five distinct LepR isoforms that have been identified are designated 
LepRa-LepRe (64).  Of these, LepRa-LepRd contain identical extracellular and 
transmembrane domains, but diverge in sequence because of splicing at 3’ exons, while 
LepRe only contains an extracellular domain.  The LepRb specific exon encodes a longer 
intracellular domain than other LepRs.  The short forms of LepR (a, c, d) are widely 
found in the periphery (65) and although their function is not clear, their roles may 
include the transport of leptin, especially across the blood-brain barrier (BBB) (66;67).  
In all species, LepRb appears to account for most if not all of leptin action (61;68-70) 
since loss of LepRb in db/db mice results in the same phenotype observed in leptin-
deficient ob/ob mice.   
Leptin receptor distribution in the brain 
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While LepRb may be expressed in other tissues, central nervous system (CNS) 
LepRb accounts for the majority of its role in energy balance (35;51;71-73).  LepRb is 
expressed in a variety of brain regions, including the hypothalamus and the hindbrain 
(74-77) (Figure 1.2).  The arcuate nucleus of the hypothalamus (ARC) is the most 
sensitive area for circulating leptin compared to other hypothalamic sites and baseline 
leptin levels are sufficient to stimulate LepRb neurons that contact the portal circulation 
of the median eminence (ME), outside the BBB (78).  While many hypothalamic nuclei 
contain LepRb-expressing neurons, two populations of LepRb neurons within the ARC 
define an important, well-understood and approachable neural circuit (74;79).  Leptin 
promotes the expression and secretion of anorexigenic peptides derived from 
proopiomelanocortin (POMC) in POMC-expressing ARC neurons, while blocking the 
synthesis and secretion of orexigenic agouti-related peptide (AgRP) and neuropeptide-Y 
(NPY) from ARC neurons that express these peptides (Figure 1.3).  LepRb-expressing 
neurons in the ventromedial hypothalamic nucleus and the ventral tegmental area also 
regulate feeding (80;81) and many other large populations of LepRb-expressing neurons 
(in regions such as the dorsomedial hypothalamic nucleus, the lateral hypothalamic 
area, the ventral premammillary nucleus, and others) most likely participate as well 
(74;79). 
Leptin receptor signaling 
Leptin binding to LepRb initiates a cascade of signaling events beginning with the 
activation of the constitutively receptor-associated Janus kinase-2 (Jak2), a tyrosine 
kinase; this represents a crucial step, as LepRb has no intrinsic enzymatic activity of its 
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own (61;82).  In addition to promoting the autophosphorylation of Jak2 to increase its 
activation, Jak2 stimulates the phosphorylation of multiple residues on the intracellular 
domain of LepRb: Tyr985, Tyr1077 and Tyr1138 (83).  Each of these phosphorylation sites lies 
in a unique amino-acid motif, and each of these residues  thus recruits a distinct set of 
downstream signaling proteins when phosphorylated (Figure 1.4).  In cultured cells, 
phosphorylated Tyr985 recruits the SH2-containing tyrosine phosphatase-2 (SHP2) to 
mediate the first step in the activation of the extracellular signal-regulated kinase (ERK) 
cascade (83-85).  Phosphorylated Tyr985 also binds the suppressor of cytokine signaling-3 
(SOCS3), which serves as a negative regulator of LepRb signaling (86).  Tyr1138  recruits 
the signal transducer and activator of transcription-3 (STAT3), a latent transcription 
factor that then becomes phosphorylated, translocates to the nucleus, and mediates the 
regulation of gene expression (84;87). Tyr1138STAT3 signaling promotes the expression 
of SOCS3, as the afferent arm of a feedback loop that attenuates LepRb signaling 
(84;86;88) (Figure 1.4).  Also, the detection of leptin-induced pSTAT3 by 
immunohistochemistry (IHC) or immunoblotting (IB) techniques mirrors LepRb 
activation and function in the CNS (89;90).  The phosphorylation of Tyr1077 promotes the 
recruitment, tyrosine phosphorylation, and transcriptional activation of STAT5, although 
Tyr1138 may also play a minor role in the regulation of STAT5 phosphorylation (83;91).  
Moreover, there are Jak2-dependent signals given that phosphorylated Jak2 (at Tyr813) 
binds to the SH2 domain of SH2B2 (92), which is an endogenous enhancer of leptin 
signaling, and genetic deletion of SH2B2 results in leptin resistance and obesity (93).  
Leptin additionally regulates a number of other intracellular signaling pathways by 
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mechanisms that remain to be clarified, including the activation of phosphatidylinositol 
kinase-3 (PI3K), the mammalian target of rapamycin (mTOR) and the inhibition of the 
AMP-dependent protein kinase (94-97).  The complexity of the signaling pathways 
regulated by leptin becomes apparent when we consider the opposite regulation of 
some signals by leptin in distinct types of LepRb neurons.  For instance, while leptin 
promotes the activation of PI3K in POMC neurons, it inhibits PI3K in AgRP neurons 
(98;99).  Therefore, the analysis of how leptin and LepRb regulate these signaling 
pathways requires further studies in vivo.  
The role of individual LepRb signals in leptin action in vivo   
In the Myers laboratory, we have probed the function of specific LepRb tyrosine 
residues/signaling pathways in vivo by the generation and study of homologously 
targeted “knock-in” mice in which sequences encoding substitution mutants of specific 
LepRb phosphorylation sites replace the endogenous lepr allele (22;100).  This approach 
expresses LepRb mutants from the lepr locus, ensuring their correct level and site of 
expression.  This ongoing analysis has revealed a crucial role for Tyr1138 in the regulation 
of feeding and overall energy expenditure, but has also revealed that this signaling 
pathway is not required for the control of fertility, immune function, or several other 
leptin actions (40;64;101;102).  The finding of similarly dysregulated feeding and body 
adiposity in mice null for STAT3 in the CNS (NStat3KO) compared to those mutant for 
LepRb Tyr1138 (Lepr
s1138/s1138) is consistent with the role for the Tyr1138STAT3 pathway 
in energy homeostasis (103).  The infertility of NStat3KO mice, which contrasts with the 
reproductive competence of Leprs1138/s1138 animals, may reflect the importance of 
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neuronal STAT3 in the response to estrogen (and perhaps other factors), as well as 
leptin (104).  Insulin resistance and glucose intolerance are improved in Leprs1138/s1138 
mice compared to db/db animals suggesting that LepRb/STAT3-independent signals may 
contribute to the regulation of glucose homeostasis by leptin.  Thus, in addition to 
LepRb/STAT3-mediated adiposity signals, non-LepRb/STAT3 leptin signals mediate an 
important adiposity-independent role in promoting glycemic control (40). 
In contrast to the hyperphagic and obese phenotype of animals mutant for 
Tyr1138, mice carrying a mutation of Tyr985 (Lepr
l985/l985) demonstrate a lean phenotype 
with exaggerated leptin sensitivity.  Additionally, Leprl985/l985 mice exhibit normal 
neuroendocrine function.  Thus, in vivo, the major role of Tyr985 appears to be in the 
attenuation of LepRb signaling, presumably via the SOCS3-mediated feedback loop 
(100).  The physiologic role for SHP2-mediated signaling in LepRb action thus remains 
unclear. 
Furthermore, mice with the intracellular domain of LepRb containing only the 
Jak2 binding site (LepRb∆/LepRb∆ mice) have a phenotype that closely resembles db/db 
mice (105), suggesting that leptin action is primarily mediated by pathways controlled 
by the phosphorylation of tyrosine residues within LepRb.   
While leptin reportedly stimulates the activity of the mammalian target of 
rapamycin complex 1 (mTORC1) pathway, and leptin’s anorectic response is known to 
be dependent on hypothalamic mTORC1 signaling (94), LepRb poorly regulates mTORC1 
signaling in cultured cells, although Tyr985 mediates the phosphorylation of ribosomal 
protein S6 via the Rsk pathway (83).     
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The knowledge of the biology and the physiological effects of leptin have 
contributed greatly to our understanding of the processes that control energy intake 
and expenditure, but we are still at an early stage in the investigation of the molecular 
mechanisms by which LepRb controls neuronal physiology.  It is thus important to 
determine how leptin controls these other physiological aspects via LepRb.  We already 
know that Tyr985 regulates LepRb feedback and that Tyr1138 is mostly responsible for the 
regulation of feeding and adiposity, but numerous aspects of leptin signaling remain 
unclear, including the mechanism by which leptin controls mTORC1 in vivo, and the role 
for LepRb-Tyr1077 in the overall regulation of physiology.   
Given our inability to detect the regulation of mTORC1 by LepRb in cultured cells, 
we postulate that the regulation of mTORC1 in vivo may be indirect of LepRb, as via the 
regulation of neural physiology.  We will thus study the activation of neuronal activation 
(and hypothalamic mTORC1) in response to leptin and other nutritional cues.  We also 
postulate that LepRb-Tyr1077 regulates physiological functions not attributable to Jak2-
autonomous signals, LepRb-Tyr985 or -Tyr1138, such as reproduction and glucose 
homeostasis.   
To test the aforementioned hypotheses and for the fulfillment of this doctoral 
dissertation, I propose the following specific aims: (1) Determine the regulation of the 
mTORC1 pathway in the basomedial hypothalamus by examining the regulation of 
mTORC1 by nutritional/metabolic cues such as leptin, LepRb signals, insulin, ghrelin, and 
fasting, and by investigating the site (neuronal populations) of mTORC1 activation in the 
arcuate nucleus (ARC) in response to the above cues; (2) Investigate the role of LepRb-
12 
 
Tyr1077 in vivo by examining leptin action in mice with replacement of Tyr1077 
(Leprf1077/f1077).   
These studies will be crucial as we seek to elucidate the complete mechanism of 
leptin action, and these results will hopefully identify pathways that may be targeted for 






































Figure 1.1: Leptin acts on the central nervous system to control physiology  
Leptin is a hormone secreted by the adipocytes in proportion to fat (energy) stores.  It 
travels in the circulation into the brain where it binds to leptin receptor (LepRb)-
expressing cells to increase metabolic rate, promote thyroid function reproduction and 
growth. Leptin also suppresses feeding and corticosteroids, and increases immune 
response. Leptin resistance is a poorly understood process in obesity that blocks 
inhibition of feeding by leptin (Adapted from Bates, S., The role of leptin receptor 









Figure 1.2: Leptin receptor expression in the hypothalamus 
Coronal section (30µm) showing the neuroanatomical distribution 
of leptin receptor-expressing cells (anti- GFP) within the 
basomedial hypothalamus. 3v-third ventricle; ARC-arcuate nucleus; 
VMH-ventromedial hypothalamus; DMH-dorsomedial 
hypothalamus; LHA-lateral hypothalamic area; ME-median 






























Figure 1.3: Neuronal circuits in the ARC 
Diagram of a coronal section of the mouse brain (left, from Schwartz, 
M.W., et. al. Central nervous system control of food intake, Nature, 
2000) and a model of the effect of leptin in hypothalamic 
neuropeptides in a zoomed-in diagram of the ARC (right) where leptin 
activates anorexigenic (POMC) neurons and inhibits orexigenic 
(AgRP/NPY) neurons to control energy homeostasis. These neurons 
synapse to other hypothalamic areas that are also known to express 
the long form of the leptin receptor (LepRb). 3v-third ventricle; ARC-
arcuate nucleus; DMH-dorsomedial hypothalamus; PVN-





















Figure 1.4: Leptin receptor (LepRb) signaling pathways 
Leptin binding to the long form of the leptin receptor (LepRb) activates the 
associated Janus kinase-2 (Jak2), which autophosphorylates and activates 
downstream tyrosine residues (Tyr985, Tyr1077, Tyr1138).  LepRb- Tyr985 recruits 
SHP-2 which recruits GRB2 and activates the ERK signaling cascade.  
Phosphorylated Tyr1138 recruits the signal transducer and activator of 
transcription-3 (STAT3) and its nuclear translocation mediates transcription of 
several genes including the suppressor of cytokine signaling-3 (SOCS3) which 
binds to Tyr985 and promotes feedback inhibition of LepRb signaling. LepRb- 
Tyr1138 STAT3 is a very important pathway on the regulation of anorexia and 
energy expenditure, whereas LepRb-Tyr1077 mediates the recruitment of STAT5. 
Altogether, these signaling pathways regulate leptin-dependent physiological 
functions such as energy balance, glucose homeostasis, reproduction, immune 




























REGULATION OF THE MAMMALIAN TARGET OF RAPAMYCIN COMPLEX-1 (mTORC1) 




The medial basal hypothalamus (MBH), including the arcuate nucleus (ARC) and 
the ventromedial hypothalamic nucleus (VMH), integrates signals of energy status to 
modulate metabolism and energy balance.  Leptin and feeding regulate the mammalian 
target of rapamycin complex 1 (mTORC1) in the hypothalamus, and hypothalamic 
mTORC1 contributes to the control of feeding and energy balance.  To determine the 
mechanisms by which leptin modulates mTORC1 in specific hypothalamic neurons, we 
immunohistochemically assessed the mTORC1-dependent phosphorylation of ribosomal 
protein S6 (pS6).  In addition to confirming the modulation of ARC mTORC1 activity by 
acute leptin treatment, this analysis revealed the robust activation of mTORC1-
dependent ARC pS6 in response to fasting and leptin deficiency in leptin receptor-
expressing Agouti-related protein (AgRP) neurons.  In contrast, fasting and leptin 
deficiency suppress VMH mTORC1 signaling.  The appropriate regulation of ARC 
mTORC1 by mutant LepRb isoforms correlated with their ability to suppress the activity 
of AgRP neurons, suggesting the potential stimulation of mTORC1 by neuronal activity.  
Indeed, fasting- and leptin deficiency-induced pS6-immunoreactivity (IR) extensively 
colocalized with cFos-IR in ARC and VMH neurons.  Furthermore, ghrelin, which 
activates orexigenic ARC neurons, increased ARC mTORC1 activity and induced 
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colocalized pS6- and cFos-IR.  Thus, neuronal activity promotes mTORC1/pS6 in 
response to signals of energy deficit.  In contrast, insulin, which activates mTORC1 via 
the phosphatidylinositol 3-kinase pathway, increased ARC and VMH pS6-IR in the 
absence of neuronal activation.  The regulation of mTORC1 in the basomedial 
hypothalamus thus varies by cell and stimulus type, as opposed to responding in a 
uniform manner to nutritional and hormonal perturbations.  
 
INTRODUCTION 
The prevalence of obesity and its pathologic sequelae, including type-2 diabetes 
and cardiovascular disease, has reached epidemic levels and continues to increase in 
developed countries (3-5;106).  Understanding the mechanisms that regulate feeding 
and energy balance thus represents a crucial first step in identifying potential targets for 
the therapy of obesity and diabetes.  The discovery of leptin and the elucidation of 
crucial leptin-regulated neurons in the brain have facilitated the study of these 
mechanisms.  Adipocytes secrete leptin in approximate proportion to fat/energy 
storage, so that circulating leptin levels reflect the status of long-term energy stores 
(28).  Adequate leptin levels signal via a specific long-form leptin receptor (LepRb) on 
metabolic sensing neurons in the brain to modulate food intake, metabolism, and 
neuroendocrine energy utilization (107-109).   
Numerous specialized neural populations in the brain express LepRb, including 
those in several basomedial hypothalamic nuclei important for energy balance, such as 
the arcuate nucleus (ARC) and the ventromedial hypothalamic nucleus (VMH).  The ARC 
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in particular contains a well-studied and -understood circuit composed of two distinct 
neural populations (29;109;110).  Proopiomelanocortin (POMC)-expressing neurons 
secrete peptides that act via central melanocortin (and perhaps other) receptors to 
suppress appetite and increase metabolic rate; leptin promotes the activity of these 
neurons (111).  In contrast, leptin suppresses the activity of ARC neurons that express 
and secrete neuropeptide Y (NPY) and Agouti-related protein (AgRP), both of which 
stimulate appetite and decrease energy utilization (112).  In addition to responding to 
leptin, many ARC neurons sense and respond to other indicators of energy status, 
including insulin and a variety of nutrients (113-115).     
Among the indicators of cellular energy status implicated in the regulation of ARC 
neural circuits are the AMP-dependent protein kinase (AMPK, which is activated in 
response to increased AMP/ATP ratios, among other signals of decreased cellular 
energy) (95;116), and the mammalian target of rapamycin (mTOR) (94;117).  mTOR 
functions within two distinct multimolecular complexes; of these, mTOR complex 1 
(mTORC1) responds to nutritional (especially amino acid) cues of energy repletion to 
promote macromolecular biosynthesis (118-120).  Insulin similarly promotes anabolic 
mTORC1 action, as does signaling via protein kinase C, Ca+2, and other pathways.  
Among other downstream signals, stimulation of mTORC1 activates the S6 kinases (S6K1 
and S6K2) to promote the phosphorylation of ribosomal protein S6 (pS6), an important 
regulator of protein translation (118;121).  Acute rapamycin treatment specifically 
inhibits mTORC1 and mTORC1-dependent signals, such as S6K1/2 (119;120).  Refeeding-
, amino acid-, and leptin-stimulated activation of mTORC1-dependent signals in whole 
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ARC, and hypothalamic mTORC1 activity is important for the anorectic response to 
amino acids and leptin (94).  In contrast, constitutive mTORC1 signaling in POMC 
neurons impairs their anorectic action and promotes obesity (122).   
These data suggest the potential complexity, and neural cell type-specificity, of 
mTOR regulation by signals of nutritional status and energy sufficiency.  We thus sought 
to determine the mechanisms by which leptin and LepRb control mTORC1 activity in 
defined populations of ARC neurons.  Consistent with the complexity of hypothalamic 
mTORC1 action, we report that while leptin modestly increases mTORC1 in the ARC, ARC 
mTORC1 is also stimulated by the activation of orexigenic AgRP neurons in response to 
leptin deficiency and other signals of negative energy balance.  In contrast, VMH 
neuronal activity and mTORC1 are conversely attenuated by signals of negative energy 
balance.  Insulin activates mTORC1 more widely and by neural activity-independent 
mechanisms.    
 
MATERIALS AND METHODS 
Reagents  
Leptin was from NHPP (Torrance, CA), insulin was from Novo Nordisk (Princeton, 
NJ), and ghrelin was the gift of Matthias Tschöp, M.D. (University of Cincinnati, 
Cincinnati, OH).  Rabbit anti-phospho S6 (Ser 240/244) was purchased from Cell 
Signaling (Boston, MA), chicken anti-GFP from Ab-cam (Cambridge, MA), goat anti-cFos 
was from Oncogene Sciences (Uniondale, NY), goat anti- β -Gal from Biogenesis (Poole, 
UK), and donkey serum was from Jackson ImmunoResearch Laboratories, Inc. (West 
22 
 
Grove, PA).  Donkey anti-chicken (or anti-rabbit) Alexa-488 conjugated and donkey anti-
goat Alexa-564 conjugated antibodies were purchased from Molecular Probes, Inc. 
(Eugene, OR).  All other immunohistochemical supplies were purchased from Sigma-
Aldrich (St. Louis, MO).  
Animals 
Animals for immunohistochemical analysis were bred in our colony in the Unit for 
Laboratory Animal Medicine (ULAM) at the University of Michigan, except for 10-12 
weeks old male S6K1-/- animals (123), which were produced by heterozygote 
intercrosses at the University of Cincinnati Genome Research Institute animal facility.  
All procedures were in accordance with the guidelines of and with the approval of the 
respective University Committee on the Care and Use of Animals at the University of 
Michigan and University of Cincinnati.  
Mice containing the coding sequence of Cre recombinase targeted into the 3’-
untranslated region of the LepRb-specific exon 18b in the Lepr gene (LepRbcre mice) 
were bred with Gt-(ROSA)26Sortm2sho (Rosa26-EGFP) mice, in which a floxed 
transcription blocker precedes the EGFP reporter gene sequence.  Cre-mediated 
recombination/removal of the transcription blocker results in EGFP expression in LepRb-
expressing cells (LepRbEGFP “reporter” mice) (124).  Heterozygote Leprdb (db/+), 
LeprTm1mgmj (s/+) (101), and LeprTm2mgmj (l/+) (125) mice were self-crossed to generate 
animals homozygous for each altered lepr allele.  Heterozygous mice expressing LacZ 
from the AgRP locus (a/+) were produced as previously described (126). 
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Mice were housed in groups of 2-4 with ad libitum access to food and water.  Some 
mice were fasted for 24 hours (or as indicated) before sacrifice between 9 a.m. and 12 
p.m.; access to water was not restricted.  For immunohistochemical analysis, ad libitum-
fed animals remained with food in the cage until (9 a.m. and 12 p.m.) the day of sacrifice 
between.  
Intraperitoneal (IP)/Intracerebroventricular (ICV) injections  
10-12 weeks-old male mice received an ip injection of leptin (5mg/kg), insulin 
(400mU/mL), or 1X sterile phosphate buffered saline (PBS) for one hour prior to 
sacrifice.  Stereotaxic implantation of cannulae was performed under isoflurane 
anesthesia into the left cerebral ventricle.  After 7 days of recovery, 3µl of leptin 
(1mg/mL), PBS, ghrelin (2µg/µl), insulin (300mU/ml), DMSO, or rapamycin (2µg/µl) were 
injected icv one hour prior to sacrifice. 
Perfusion and Immunohistochemistry (IHC)  
Handling of all animals was limited to <1 hour prior to anesthesia and perfusion to 
minimize stress-related induction of c-Fos levels.  Perfusion and IHC procedures were 
performed essentially as described previously (90). In brief, mice were deeply 
anesthetized with an overdose of pentobarbital (150 mg/kg, IP) and transcardially 
perfused with sterile PBS followed by 4% paraformaldehyde.  Brains were removed, 
post-fixed and cryoprotected before sectioning into 30μm coronal slices, which were 
collected into 4 representative series and stored at -20˚C until further use.  
For IHC, sections were pretreated in ice-cold methanol, 0.6% glycine and 0.03% SDS, 
and then blocked with donkey serum and incubated in the primary antibodies (rabbit-
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anti-pS6 [1:100], chicken anti-GFP [1:1000], goat anti-c-Fos [1:1000] and/or goat anti-β-
Gal [1:3000]).  Detection of primary antibodies was done by immunofluorescence 
(donkey anti-chicken (or anti-rabbit)-Alexa 488 and anti-goat-Alexa 564 [all 1:200 
dilution]). 
Quantification of IHC signals from hypothalamic sections and statistics  
 Regions of the hypothalamus denoted as ARC and VMH for counting purposes 
are depicted in Figure 2.1.  For quantification of pS6-positive neurons, LepRb (EGFP) 
neurons, AgRP neurons and pS6/EGFP, pS6/AgRP or pS6/c-Fos double-labeled neurons, 
pictures of matched brain areas were taken on channels for Alexa 488 and Alexa 564 
from at least three sections containing the arcuate nucleus (ARC) of the hypothalamus 
for each brain between bregma -1.58mm to -1.94mm (according to the Paxinos and 
Franklin mouse brain atlas).  All sections were arranged from rostral to caudal to 
examine the distribution of single- and double-labeled neurons.  Using Adobe® 
Photoshop software, both channels (red and green) were combined in a RGB picture 
and single and double-labeled neurons were counted and recorded digitally to prevent 
multiple counts.  Total number of single- and double-labeled neurons was presented as 
means +/- SEM and differences were analyzed by two-way ANOVA followed by a 
Student’s T-test to determine significant differences between groups.  Differences were 
accepted for p values < 0.05, with an n value ≥ 3.  
 
RESULTS 




 In order to more closely examine the molecular mechanisms and cellular 
specificity of the regulation of the mTORC1 pathway by leptin, we employed the 
immunohistochemical detection of pS6-IR as a marker for mTORC1 activity in the 
hypothalamus.  Reasoning that decreased baseline levels of leptin would facilitate the 
detection of the leptin response, we examined pS6-IR in the hypothalamus of ad 
libitum-fed and 24-hour fasted wild-type (+/+) mice following treatment with leptin (5 
mg/kg, ip) or vehicle (Figure 2.2).  This analysis revealed an increased number of pS6-IR 
ARC neurons in fasted +/+ animals with and without leptin treatment, but only a trend 
toward increased numbers of pS6-IR neurons with leptin in the ad libitum-fed animals.  
In contrast to the ARC, fasting suppressed pS6-IR in the VMH.  (See Figure 2.1 for 
depictions of the regions counted for this and subsequent analyses).  We also compared 
ad libitum fed +/+ mice to leptin-deficient (Lepob/ob) mice (Figure 2.3), revealing an 
increase in the number of pS6-IR ARC neurons and a trend toward decreased pS6-IR in 
VMH neurons (p= 0.06) in Lepob/ob animals relative to ad libitum-fed controls.  This 
increase in the number of pS6-IR ARC neurons was especially pronounced in the medial 
basal ARC (MB-ARC) near the median eminence.  These findings suggested that fasting 
and leptin deficiency mediate the phosphorylation of S6 in MB-ARC neurons, and also 
that the conditions of leptin repletion or the increased MB-ARC pS6-IR at baseline with 
24 hour-fasting impair our ability to examine leptin-mediated stimulation of pS6-IR.  We 
thus re-examined the leptin effect in animals that had been fasted for a shorter period 
of time (overnight, approximately 16 hours) (Figure 2.4).  This analysis revealed an 
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increase in pS6-IR neurons with leptin treatment in the MB-ARC similar to that 
previously described in rats following a similarly modest fast (94). 
Since the finding of MB-ARC mTORC1 activation implied by the increased MB-ARC 
pS6-IR in fasted and Lepob/ob animals was unexpected, we examined the mTORC1-
dependency of the fasting effect by examining pS6-IR in S6K1-/- animals (123) and in 
animals treated with intracerebroventricular (ICV) rapamycin (a specific mTORC1 
inhibitor, when used acutely) (118-120).  S6K1 and the related S6K2 interact with and 
are activated by mTORC1 to mediate the mTORC1-dependent phosphorylation of S6.  
Lack of S6K1 significantly decreased pS6-IR in the MB-ARC of knockout mice under ad 
libitum and fasted conditions compared to wild type mice under similar conditions 
(Figure 2.5).  S6K1-/- animals exhibited some residual pS6-IR in the fasted state, however, 
suggesting that while S6K1 mediates a portion of the basal and fasting-induced pS6-IR in 
the MB-ARC, other kinases (e.g. S6K2) also contribute.  ICV rapamycin treatment 
abrogated MB-ARC pS6-IR (including during fasting), demonstrating the mTORC1-
dependence of pS6-IR in the MB-ARC (Figure 2.6).  Thus, fasting promotes increased 
mTORC1 activity in neurons of the MB-ARC in mice. 
Neuronal populations demonstrating pS6-IR in the MB-ARC  
 In order to determine whether the fasting-mediated activation of pS6 occurred in 
LepRb-expressing neurons, we examined pS6-IR and its colocalization with EGFP in 
LepRbEGFP mice, which demonstrate EGFP expression specifically in LepRb-expressing 
neurons throughout the brain (75;127;128).  Since LepRb is expressed normally in the 
LepRbEGFP animals, they exhibit no detectable alterations in energy homeostasis.  As 
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previously, fasting increased pS6-IR in the MB-ARC of LepRbEGFP mice, and leptin 
treatment tended to increase the number of pS6-IR neurons (Figure 2.7).  Furthermore, 
the fasting-stimulated pS6-IR neurons extensively colocalized with LepRb/EGFP neurons; 
approximately 40% of MB-ARC LepRb neurons demonstrated fasting-induced pS6-IR.   
The similarity of the distribution of MB-ARC neurons that demonstrated fasting- (or 
leptin deficiency-) induced pS6-IR with the distribution of orexigenic NPY/AgRP-
expressing MB-ARC neurons suggested the possibility that these neurons might 
represent a major locus of fasting-induced pS6-IR.  We thus utilized animals 
heterozygous for AgrpLacZ (in which the homologous targeting of the coding sequences 
for LacZ mediates the expression of β -galactosidase (β -gal) by the native AgRP 
promoter, and specifically in AgRP-expressing neurons) (126;129) in order to examine 
the potential induction of pS6-IR in AgRP neurons during fasting (Figure 2.8 and Figure 
2.9).  These AgrpLacZ heterozygous animals have no detectable alteration in energy 
balance relative to control animals.  While little pS6-IR colocalized with the detectable 
AgRP neurons in fed animals, pS6-IR was extensively colocalized with β-gal/AgRP 
neurons in fasted animals (20-30% of the total pS6 neurons in the MB-ARC of fasted 
animals were AgRP positive). Thus, fasting promotes mTORC1 activity in LepRb- and 
AgRP-expressing neurons in the MB-ARC.  Similar results were noted throughout the 
rostal-caudal axis of the ARC (Figure 2.9). 
Role of LepRb signaling in the regulation of pS6 by endogenous leptin in the MB-ARC   
 
 The finding of increased pS6-IR observed in the MB-ARC of Lepob/ob animals 
suggested that increased mTORC1 activity results from the absence of a LepRb-
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mediated signaling pathway.  In order to determine the potential mechanism by which 
endogenous leptin might act via LepRb in wild-type animals to regulate MB-ARC pS6-IR, 
we examined pS6-IR in the ARC of mouse models containing specific alterations in LepRb 
signaling (Figure 2.10).  As in leptin-deficient Lepob/ob animals, Leprdb/db animals (in which 
LepRb is disrupted by a splicing defect) displayed a large number of pS6-IR MB-ARC 
neurons compared to controls, suggesting that the appropriate regulation of mTORC1 
activity in MB-ARC neurons by endogenous leptin requires intact LepRb.  We also 
examined pS6-IR in mice containing mutant LepRb molecules with substitution 
mutations of tyrosine residues that control specific signaling pathways.  In contrast to 
the Lepob/ob and Leprdb/db animals, however, ad libitum fed mice containing a mutation of 
LepRb Tyr985 (Lepr
l985/l985 (l/l) mice) (130) or Tyr1138 (Lepr
s1138/s1138 (s/s) mice) (101) 
demonstrated little pS6-IR in the MB-ARC (Figure 2.10), suggesting that the signals 
controlled by these residues (SHP2/SOCS3 and STAT3, respectively) are not required for 
the normal modulation of mTORC1 activity by endogenous leptin in the MB-ARC.  While 
their morbid obesity impairs the examination of the fasting response in s/s animals, we 
examined the effect of fasting in l/l mice, which revealed the fasting-mediated induction 
of pS6-IR in the MB-ARC in these animals, ruling out an effect of Tyr985 in the regulation 
of this effect. 
Neuronal activation and S6 phosphorylation in the MB-ARC and VMH 
 As we sought to understand the mechanisms by which fasting and/or the absence 
of leptin action might activate mTORC1 in the MB-ARC and decrease mTORC1 in the 
VMH, we noted that the induction of MB-ARC pS6-IR correlated with the activation of 
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orexigenic neurons, such as AgRP neurons.  These neurons are activated by fasting in 
wild-type mice and also in the ad libitum-fed state in Lepob/ob and in Leprdb/db animals, 
but not in l/l or s/s mice (29;109;131;132)(Figure 2.11).   
To examine this correlation more closely, we examined the potential colocalization 
of pS6-IR and c-Fos-IR (a marker of neuronal activation) (133) in the MB-ARC and VMH 
during fasting and leptin treatment (Figure 2.12).  In addition to demonstrating the 
expected induction of MB-ARC pS6 and c-Fos-IR by fasting, 54% of the pS6-IR neurons in 
fasted mice colocalized with c-Fos-IR, suggesting that the majority of the neurons of the 
MB-ARC that contain highly active mTORC1 represent actively firing neurons.  
Furthermore, fasting decreased VMH pS6-IR and tended to decrease VMH c-Fos-IR.  
Neither fasting nor leptin altered the percentage of MB-ARC or VMH pS6-IR neurons 
positive for c-Fos-IR, consistent with the idea that the regulation of c-Fos/neuronal 
activation is tightly coupled to pS6/mTORC1. 
It is, of course, possible that mTORC1 activation might promote neuronal activation, 
rather than the converse.  In order to address this issue, we treated fasted animals with 
ICV rapamycin before sacrificing them for the examination of pS6-IR and c-Fos-IR in the 
MB-ARC (Figure 2.13).  While, as expected, rapamycin treatment abrogated the 
mTORC1-dependent pS6-IR in the MB-ARC, c-Fos-IR remained high.  Thus, while most 
pS6-IR neurons in the MB-ARC neurons of fasted mice are active by the criterion of c-
Fos-IR, mTORC1 activity is not required for this neuronal activation, consistent with the 
notion that the depolarization of active neurons in the MB-ARC may induce mTORC1 
activation.   
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In order to further examine the notion that depolarization and neural firing may 
promote mTORC1 activity in the MB-ARC, we examined the induction of pS6-IR and c-
Fos-IR by treatment with ICV ghrelin, which rapidly and directly depolarizes orexigenic 
neurons in the MB-ARC (independently of any acute effects on circulating metabolites) 
(134) (Figure 2.14).  As for fasting, ICV ghrelin treatment induced pS6-IR and c-Fos-IR 
and their colocalization in the MB-ARC, consistent with the activation of mTORC1 by 
depolarization of these neurons.   
Insulin and pS6-IR in the hypothalamus  
 In order to understand the potential for additional mechanisms of hypothalamic 
mTORC1 activation, we examined pS6- and c-Fos-IR in the hypothalamus following 
insulin treatment, as insulin hyperpolarizes all studied ARC neurons, but activates 
mTORC1 via the PI 3-kinase pathway in cultured cells (135).   
Indeed, while ICV insulin treatment dramatically increased pS6-IR in the ARC and 
VMH, c-Fos-IR did not change in the ARC and decreased in the VMH, with the result that 
the percent of pS6-IR neurons containing c-Fos decreased in each region with insulin 
treatment (Figure 2.15).  Similarly, IP insulin injection increased pS6-IR in the MB-ARC 
(although not in the VMH or elsewhere in the brain), but without increasing c-Fos-IR or 
the percent of pS6-IR neurons containing c-Fos (Figure 2.16).  These data are consistent 
with the notion that insulin activates mTORC1 widely, and independently of neuronal 
activity.  Thus, the regulation of mTORC1 in the basomedial hypothalamus varies by cell 
type, nucleus, and nutritional status, as opposed to responding in a uniform manner to 





Leptin activates a variety of signals in hypothalamic LepRb neurons, such as STAT3, 
STAT5, ERK, PI3K, AMPK, and mTORC1 (84;85;85;94-96;98;136-138).  Many of these 
pathways (including STAT3, PI3K, and mTORC1) are known to play important roles in 
anorexia and other leptin-dependent responses (22;94;96;107;111;139).  While the 
receptor motifs by which LepRb activates many signals (e.g. STAT3) have been revealed 
(117;137), the mechanisms by which LepRb modulates other signals, such as PI3K, 
AMPK, and mTORC1 remain obscure.  The difficulty in dissecting these signals stems in 
large part from the inability to observe the regulation of these signals by LepRb in 
cultured cells, such as HEK293 cells, without the overexpression of multiple signaling 
proteins that likely result in the non-specific activation of some signals.  Additionally, the 
opposite regulation of some signals by leptin in distinct types of LepRb neurons 
complicates the analysis of their regulation.  For instance, while leptin promotes the 
activation of PI3K in POMC neurons, it inhibits PI3K in AgRP neurons (98;99;117).  Thus, 
the analysis of the mechanisms by which leptin regulates these signals requires further 
studies in vivo and presumably in a cell-type specific manner, as we have done here for 
the regulation of mTORC1. 
Our data reveal the IHC detection of pS6-IR in the MB-ARC to be largely dependent 
upon the major mTORC1 mediator, S6K1, and to be entirely dependent upon mTORC1 
itself.  Using this IHC methodology to explore the regulation of mTORC1 by leptin and 
nutritional manipulation (i.e. fasting) not only confirmed the expected enhancement of 
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mTORC1 signaling upon leptin treatment, but also revealed increased mTORC1 activity 
in LepRb and AgRP-expressing neurons in the MB-ARC by fasting and leptin-deficiency.  
In contrast, fasting and leptin deficiency decrease mTORC1 activity in the VMH. 
The finding that endogenous leptin prevents mTORC1 activation in the MB-ARC 
suggested potential roles for specific LepRb signals in this process.  We thus explored 
the signaling mechanisms by which LepRb might modulate the accumulation of pS6-IR in 
the MB-ARC.  This analysis revealed that neither Tyr985 (the binding site for SHP-2 and 
SOCS3) nor Tyr1138 (binding site for STAT3) participate in the regulation of MB-ARC pS6-
IR under conditions of endogenous leptin (in contrast to the activation observed in the 
absence of leptin action in Lepob/ob and Leprdb/db mice).  While the obesity and high 
circulating leptin levels of the Leprs1138/s1138 mice make it difficult to assess a role for 
Tyr1138 in the leptin-stimulated activation of mTORC1 in the ARC, the Tyr1138STAT3 
pathway represents an unlikely mediator of the acute effects of leptin on pS6-IR, since 
the regulation of this pathway is unlikely to be transcriptionally mediated. 
Our data further suggest that the mechanism by which fasting and leptin-deficiency 
mediate this activation is indirect, via the regulation of neural activity.  This conclusion is 
supported not only by the correlation between the induction of pS6-IR in the MB-ARC by 
nutritional conditions and genetic environments (Leprdb/db mice) in which these 
orexigenic neurons are activated (140;141), but also by the induction of pS6-IR primarily 
in neurons that also demonstrate IHC evidence of activation (c-Fos-IR) both in the MB-
ARC and in the oppositely-regulated VMH.  Furthermore, ghrelin, which acutely 
depolarizes the orexigenic neurons of the MB-ARC (134) without altering the overall 
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nutritional milieu, also promotes pS6-IR coincident with c-Fos-IR in the MB-ARC.  Note 
that while one hour of stimulation, which generally represents the peak of mTORC1 
activation/pS6 following an acute stimulus (and used in this study), precedes the peak of 
c-Fos-IR following neuronal depolarization; thus, the ultimate extent of c-Fos-IR 
colocalization in this experiment may be underrepresented.   
Since leptin depolarizes and promotes the firing of some neurons within the MB-
ARC (140;142), it is possible that the previously reported activation of mTORC1 during 
acute leptin treatment also takes place secondary to changes in neuronal activity.  
Another reasonable possibility is that leptin might promote mTORC1 signaling via the 
induction of PI3K, which is an important upstream activator of mTORC1 (118-120).  
Indeed, the observation that insulin (whose major signaling output is via PI3K (143)) 
promotes pS6-IR in the mediobasal hypothalamus without increasing c-Fos-IR suggests 
that robust PI3K activation in the hypothalamus stimulates mTORC1, as in cultured cells.   
Overall, our present results demonstrate that leptin and nutritional cues do not 
modulate hypothalamic mTORC1 activity in a uniform manner, but rather control 
mTORC1 via multiple pathways and, in many cases, in opposite directions in different 
cell types and brain regions, via the regulation of neuronal activity.   
 
FUTURE DIRECTIONS 
 In this study, we have completed the characterization of mTORC1 activation by 
different nutritional cues and its specific localization within the basomedial 
hypothalamus.  However, it would be interesting to assess the activation of the mTORC1 
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pathway by neuronal activation more closely by performing KCl-induced depolarization 
of ARC explants.  This could be done in the presence and absence of leptin in order to 
detect how specific activation of ARC neurons regulates pS6, which could be measured 
in the media.  Moreover, examining the role of mTORC1 on neuronal regulation, 
including neuropeptide synthesis/release and neuronal plasticity would provide 
information on the specific function of mTORC1 in the CNS.     
 Also, given that only 30% of the pS6 neurons were AgRP positive, it would be 
very interesting to know the identity of the other neurons presenting S6 activation in 
the ARC, and determine if they are also activated by fasting.  Most importantly, it would 
be crucial to determine if LepRb-Tyr1077 is the pathway by which leptin regulates 
neuronal activation and thus, indirectly turns on the mTORC1 pathway in the ARC.  And 
if so, what are the differences of the regulation of the mTORC1 pathway in the VMH, 
where mTORC1/pS6 regulation opposes what is observed in the ARC.  More specifically, 
we could investigate the role of other signaling molecules, such as PI3K and how they 
might influence neuronal activation by leptin or how PI3K activity might differ by cell-
type (within orexigenic neurons) and brain areas (ARC versus VMH).  
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Figure 2.1: Regions of interest in the basomedial hypothalamus  
Regions of interest utilized for counting cells in the ARC and VMH. Shown are pS6-IR 
images of the medial basal hypothalamus demonstrating (enclosed in yellow dashed 
lines) regions utilized for counting ARC (left panel; image from fasted wild-type animal) 
and VMH (right panel; image from ad libitum-fed wild-type animal) neurons in 
histochemical sections. Note that the indicated VMH section represents the ventrolateral 






























Figure 2.2: Phosphorylation of S6 in response to fasting and leptin in the MB-ARC   
Wild-type (+/+) animals under ad libitum fed or 24-hour fasted conditions treated with leptin 
(Lep; 5mg/kg, ip) or vehicle (Veh) for 1 hour before sacrifice that were processed for 
immunohistochemical analysis of pS6-IR.  Top panels show representative images of 
immunofluorescent detection of pS6-IR, while the graphs below show the fold induction of the 
number of pS6 cells in the MB-ARC, which were quantified and plotted as mean +/- SEM (n≥3 per 






Figure 2.3: Phosphorylation of S6 in leptin-deficient ob/ob mice   
Ad libitum fed Lepob/ob mice and +/+ mice treated with leptin (Lep; 5mg/kg, ip) or vehicle 
(Veh) for 1 hour before sacrifice that were processed for immunohistochemical analysis of 
pS6-IR.  Top panels show representative images of immunofluorescent detection of pS6-
IR, while the graphs below show the total counts of the number of pS6 cells in the MB-
ARC, which were quantified and plotted as mean +/- SEM (n≥3 per condition; bars with 


















Figure 2.4: Leptin-induced phosphorylation of S6 in wild-type mice   
Overnight (approximately 16-hour) fasted +/+ mice treated with 
leptin (Lep; 5mg/kg, ip) or vehicle (Veh) for 1 hour before sacrifice 
that were processed for immunohistochemical analysis of pS6-IR.  
Top panels show representative images of immunofluorescent 
detection of pS6-IR, while the graphs below show the fold induction 
of the number of pS6 cells in the MB-ARC, which were quantified and 
plotted as mean +/- SEM (n≥3 per condition; bars with different 

























Figure 2.5: S6K1-dependence of pS6-IR in the MB-ARC 
Wild-type (+/+) or S6K1-/- (KO) animals under ad libitum fed or 24-hour fasted 
conditions were perfused and processed for the immunofluorescent detection of 
pS6-IR.  Top panel shows representative images.  Total numbers of pS6-IR neurons 
in the MB-ARC (mean +/-SEM) for each genotype are presented in the graph.  (n≥3 
per condition; ** represents a p value <0.001 by Student’s t-test). 3V-third 
ventricle. 
 









Figure 2.6: mTORC1-dependence of pS6-IR in the MB-ARC 
Wild-type animals under the indicated ad libitum fed or fasted conditions were treated with icv 
vehicle or rapamycin (2µg/µl) overnight and 2 hours before sacrifice and processing for the 
immunofluorescent detection of pS6-IR.  Representative images under each condition are 
shown.  In addition to the MB-ARC pS6-IR that is the focus of this analysis, note some 
inflammatory induction of pS6-IR in the apendymal cells that line the ventricle, which is also 















Figure 2.7: Fasting induces pS6-IR in LepRb-
expressing neurons in the MB-ARC 
LepRbGFP mice were allowed to feed ad 
libitum or were fasted for 24 hours before 
treatment with leptin (Lep; 5 mg/kg, ip) or 
vehicle (Veh) for 1 hour prior to sacrifice and 
processing for the immunofluorescent 
detection of LepRb/GFP (green)-expression 
and pS6-IR (red). Top panels show 
representative images of pS6-IR alone (left) 
and merged pS6-IR and GFP-IR images (right).  
LepRb/GFP neurons that contain pS6-IR are 
plotted as mean +/-SEM (n≥3 per condition; 
bars with different letters were significantly 




Figure 2.8: Fasting induces pS6-IR in AgRP-expressing neurons in 
the MB-ARC 
Animals heterozygous for AgrpLacZ were allowed to feed ad 
libitum  or were fasted for 24 hours before treatment with leptin 
(Lep; 5 mg/kg, ip) or vehicle (Veh) for 1 hour prior to sacrifice and 
processing for the immunofluorescent detection of AgRP/LacZ 
(red)-expression and pS6-IR (green). Top panels show 
representative images of AgRP (β-gal) alone (top), pS6-IR alone 
(middle) and merged β-gal and pS6-IR images (bottom).  AgRP (β-
gal) neurons that contain pS6-IR are plotted as mean +/-SEM (n≥3 
per condition; bars with different letters were significantly 
















































Figure 2.9: Distribution of AgRP/pS6 cells along the rostro-
caudal axis of the MB-ARC 
Animals heterozygous for AgrpLacZ were allowed to feed ad 
libitum or were fasted for 24 hours before treatment with leptin 
(Lep; 5 mg/kg, ip) or vehicle (Veh) for 1 hour prior to sacrifice and 
processing for the immunofluorescent detection of AgRP/LacZ 
expression and pS6-IR. AgRP (β-gal) neurons that contain pS6-IR 
in each region of the MB-ARC are plotted as mean +/-SEM (n ≥ 3 
per condition; bars with different letters were significantly 
different by ANOVA, P < 0.05). These data represent data from 
Figure 3B, separately analyzed for each region of the rostrocaudal 














Figure 2.10: pS6-IR in the MB-ARC of mouse models with defects 
in LepRb signaling 
A, Ad libitum-fed wild-type (+/+), Leprdb/db (db/db), Leprs1138/s1138 
(s/s) and Leprl985/l985 (l/l) were perfused and processed for the 
immunofluorescent detection of pS6-IR.  Representative images 
of pS6-IR from each genotype are shown. B, Ad-libitum fed and 
24-hour fasted l/l mice were treated with leptin or PBS, as 
indicated, perfused, and processed for the immunofluorescent 












































Figure 2.11: C-Fos-IR in the MB-ARC of db/db 
and l/l mice 
Ad libitum-fed wild-type (+/+), db/db, or l/l 
mice were perfused and processed for the 
immunohistochemical detection of c-Fos-IR. 
Representative images are shown. Note that 
the extensive activation of c-Fos-IR in the MB-
ARC of db/db animals is absent from l/l 












Figure 2.12: pS6-IR localization in activated neurons in the MB-ARC and VMH 
Wild-type animals were allowed to feed ad libitum or were fasted for 24 hours before 
treatment with leptin (Lep; 5 mg/kg, ip) or vehicle (Veh) for 1 hour prior to sacrifice and 
processing for the immunofluorescent detection of c-Fos-IR (red) and pS6-IR (green).  
Top panels show representative images of merged images at each condition.  Smaller 
panels beneath show digital zoom of each channel and merged images from the boxed 
area in the larger panels above.  Graphs: Total numbers of pS6-IR, c-Fos-IR, and % 
double-labeled neurons are plotted as mean +/-SEM (n≥3 per condition; bars wi th 




Figure 2.13: Rapamycin abrogates pS6-IR but not cFos-IR in the MB-ARC  
Wild-type animals under the indicated ad libitum fed or overnight (approximately 16 
hours) conditions were treated with icv vehicle or rapamycin (2µg/µl) via indwelling 
catheters overnight and for additional 2 hours before sacrifice and processing for the 
immunofluorescent detection of pS6-IR (green) and c-Fos-IR (red).  Representative 
images under each condition are shown.  In addition to the MB-ARC pS6/c-Fos-IR that is 
the focus of this analysis, note some inflammatory induction of pS6-IR in the apendymal 


















Figure 2.14: Ghrelin-induced neuronal firing promotes mTORC1 
activation in the MB-ARC 
Ad libitum fed wild-type animals with indwelling icv catheters were 
treated with vehicle (Veh) or ghrelin (2µg/µl) for 1 hour before sacrifice 
and processing for the immunofluorescent analysis of pS6-IR (green) and 
c-Fos-IR (red).  Top panels:  Representative merged images.  Panels 
beneath the image from the ghrelin-treated sample represent digital zoom 
of individual channels and merged images from the boxed area in the 
larger image.  Graph: Total numbers of pS6-IR, c-Fos-IR, and double-
labeled neurons are plotted as mean +/-SEM (n≥3 per condition;  





























Figure 2.15: ICV insulin induces mTORC1 activation independently of c-Fos 
Ad libitum-fed wild type animals with indwelling ICV catheters were treated with vehicle 
(Veh) or insulin (Ins) (300 mU/mL) for 1 h before the animals were killed and processing 
for immunofluorescent analysis of pS6-IR (green) and c-Fos-IR (red). Top panels show 
representative merged images. Graphs show total number of pS6-IR, c-Fos-IR, and 
double-labeled neurons, along with percent double-labeled neurons, are plotted as 









Figure 2.16: IP insulin induces mTORC1 activation independently of c-Fos in the MB-
ARC  
Ad libitum-fed wild type animals were treated with vehicle (Veh) or insulin (Ins) (400 
mU/mL) for 1 h before the animals were killed and processing for immunofluorescent 
analysis of pS6-IR (green) and c-Fos-IR (red). Top panels show representative merged 
images. Graphs show total number of pS6-IR, c-Fos-IR, and double-labeled neurons, 
along with percent double-labeled neurons, are plotted as mean ± SEM (n ≥ 3 per 
















LEPTIN RECEPTOR-TYR1077 STAT5 SIGNALING: THE MISSING LINK BETWEEN  




Adipocytes secrete leptin in proportion to triglyceride content to communicate 
the repletion of peripheral energy stores to the brain, thereby suppressing feeding and 
permitting energy expenditure.  Leptin acts through its receptor (LepRb) -  a cytokine 
receptor that is expressed in brain regions involved in energy homeostasis.  Leptin 
binding to LepRb initiates a cascade of signaling events starting with the activation of 
Janus kinase (Jak2), which stimulates the tyrosine phosphorylation of three sites on 
LepRb.  Each site mediates the recruitment of distinct downstream signaling proteins.  
While the signals mediated by LepRb Tyr1138 and Tyr985 control important aspects of 
energy homeostasis and LepRb signal attenuation, respectively, the signaling 
mechanisms by which LepRb modulates reproductive function, and aspects of glucose 
homeostasis have remained unclear.  In order to examine the hypothesis that LepRb-
Tyr1077 (which mediates the recruitment and transcriptional activation of the signal 
transducer and activator of transcription factor-5 (STAT5)) might play a role in these and 
other leptin actions, we generated a “knock-in” mouse model containing a replacement 
of LepRb-Tyr1077 (Lepr
f1077/f1077 
mice).  In contrast to the dramatic hyperphagia and 
obesity of mice mutant for LepRb-Tyr1138, Lepr
f1077/f1077 
mice demonstrate only modest 





display marked impairment of the reproductive axis, however, with absent or delayed 
estrous cycling.  Lepr
f1077/f1077 
mice also exhibit alterations in glucose homeostasis that 
are not attributable to increased adiposity, suggesting important roles for LepRb-Tyr1077 
in glycemic control, as well.  Our results also suggest that signaling by LepRb-Tyr1077 links 
body adiposity to the neuroendocrine reproductive axis as well as to the regulation of 
glucose homeostasis; impaired signaling via this pathway could potentially contribute to 
the processes linking altered metabolism and reproduction in disease states.  
 
INTRODUCTION 
The hormone leptin is secreted into the circulation by the adipose tissue and is 
transported into the brain where it acts on neuronal populations to inhibit feeding and 
induce energy expenditure.  Leptin also modulates other physiological processes, 
including having a permissive action on reproduction (34;55-57), and regulating glucose 
homeostasis by regulating insulin production in the pancreatic β-cells (51) or by altering 
intra-hepatic glucose fluxes (144).  Activation of the leptin receptor (LepRb) induces a 
phosphorylation cascade starting with the autophosphorylation of Jak2, which then 
phosphorylates residues on LepRb (Tyr985, Tyr1077 and Tyr1138).  LepRb-Tyr1138 recruits the 
signal transducer and activator of transcription-3 (STAT3), and contributes a small 
amount to the recruitment of STAT5.  The LepRb-Tyr1138 STAT3 pathway is crucial for 
the control of energy balance and some aspects of reproduction and glucose 
homeostasis because mice with a replacement of LepRb-Tyr1138 (s/s) have preserved 
reproduction and improved diabetes compared to db/db mice.  LepRb-Tyr985 binds to 
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SHP-2 and SOCS3 and controls LepRb feedback inhibition.  Thus, leptin action relies on 
the regulation of different pathways via LepRb, but some aspects of how leptin controls 
physiology remain unclear, including the control of reproduction and glucose 
homeostasis.   
In addition to STAT3, STAT5a and STAT5b are highly expressed in specific 
populations of hypothalamic neurons in brain regions known to mediate the regulation 
of energy homeostasis (145;146).  Leptin promotes the phosphorylation and nuclear 
localization of STAT5 in the ARC of rodents (83;147), demonstrating that leptin activates 
STAT5 in vivo as well as in cultured cells and suggesting that LepRbSTAT5 signaling 
may contribute importantly to physiologic leptin action.   
Recent data from the Myers laboratory revealed a dominant role for LepRb-
Tyr1077 (which is also phosphorylated during receptor activation) and a secondary role 
for LepRb-Tyr1138 in the acute phosphorylation of STAT5a and STAT5b (83).  Although the 
two isoforms of STAT5 (STAT5a and STAT5b) represent the products of distinct genes, 
the two genes lie in close proximity, enabling the generation of a conditional Stat5fl 
allele in which the coding regions for both STAT5 isoforms can be excised in a single 
event (148;149).  Deletion of Stat5fl in the hypothalamus or throughout the CNS of mice 
(via RIP-cre or Nestin-cre, respectively) results in late-onset obesity with hyperphagia, 
impaired thermal regulation in response to cold, hyperleptinemia and insulin resistance, 
suggesting an important role for brain STAT5 in the regulation of energy balance (150).  
It remains unclear whether the obesity of these mice reflects the role for STAT5 in leptin 
action in vivo, however, as many factors other than leptin also regulate STAT5.  In fact, a 
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variety of other cytokines and growth factors, including granulocyte macrophage colony 
stimulating factor (GM-CSF), growth hormone, prolactin, erythropoietin, and others 
promote the phosphorylation and transcriptional activation of STAT5 in cells expressing 
the cognate receptors for these ligands (150).  Indeed, the anorexic response to CNS 
GM-CSF treatment is attenuated in Nestin-cre;Stat5fl animals, demonstrating that at 
least a portion of the phenotype of these animals likely follows from leptin-independent 
mechanisms (150).   
Furthermore, the neuroanatomical site at which STAT5 acts to mediate energy 
balance is not clear: RIP-cre and Nestin-cre mediate deletion in some (but not all) LepRb-
expressing neurons and mediate excision in many non-LepRb-expressing neurons.  
Absence of STAT5 in the CNS does not alter mRNA expression of leptin’s known targets 
within the ARC (i.e. POMC, AgRP, and NPY) suggesting that other genes must represent 
the key transcriptional targets of STAT5 in the regulation of energy balance.   
In order to directly assess the physiological role of the LepRb-Tyr1077 STAT5 
signaling pathway, we generated a “knock-in” mouse model containing a replacement 
on LepRb-Tyr1077
 (Tyr1077 to Phe1077).  We hypothesized that LepRb-Tyr1077STAT5 is an 
important leptin-dependent signaling pathway that contributes to reproduction and 
glucose homeostasis, but only modestly to energy balance.    
 




Leptin was the generous gift of Amylin Pharmaceuticals (San Diego, CA), insulin was 
from Novo Nordisk (Novolin), and 30% dextrose was from Hospira Inc. High fat diet (45% 
Kcal fat) chow was from Research Diets, NJ.  Rabbit anti-phospho-STAT3 (Y709) was 
purchased from Cell Signaling (Boston, MA), and donkey serum was from Jackson 
ImmunoResearch Laboratories, Inc. (West Grove, PA).  Donkey anti-rabbit Alexa-488 
conjugated antibodies were purchased from Molecular Probes, Inc. (Eugene, OR).  All 
other immunohistochemical supplies were purchased from Sigma-Aldrich (St. Louis, 
MO).  
Animals 
Unless otherwise stated, animals were bred in our colony in the Unit for 
Laboratory Animal Medicine (ULAM) at the University of Michigan and handled in 
accordance with The University Committee on Use and Care of Animals (UCUCA).  
Tg(EIIa-cre)C5379Lmgd/J (C57Bl6 nII) mice were purchased from Jackson Laboratories.  
This transgenic line carries a cre transgene under the control of the EIIa (adenovirus) 
promoter that targets expression of Cre recombinase to the mouse embryo.  Cre-
mediated recombination in these animals is widely spread, including in the germ cells 
that transmit the genetic alteration to the progeny (151). 
Generation, backcrossing and deletion of “neo” cassette in LepRbf1077/f1077 mice 
Targeted 129Sv embryonic stem (ES) cell clones were used to produce chimeric 
animals, which were crossed with C57Bl/6J mice to generate heterozygous leprf1077/+ 
(f/+) “knock-in” F1 mice expressing LepRbF1077 from the genomic context of endogenous 
LepRb.  Heterozygous f/+ mice were crossed with B6.FVB-Tg(EIIa-cre)C5379Lmgd/J mice 
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to remove the “floxed” neomycin (neo) cassette found in the original targeting vector 
(Figure 3.1) and used for screening purposes during the targeting of leprF1077 in ES cells.  
Successful deletion of the neo cassette was tested by Southern blot analysis (of tail DNA 
samples) with DIG-labeled neo probe to confirm deletion of neo.  These animals were 
bred to C57Bl/6J mice to eliminate the cre transgene.  Interbreeding of the resulting n2 
C57Bl/6J heterozygous animals (LeprPhe1077/+) yielded homozygous (f/f) and wild-type 
(+/+) mice for study.    
Phenotyping studies  
Mice were single housed with ad libitum access to food and water, and   male 
and female mice were weighed weekly beginning at 4-weeks to 12-weeks of age.  Food 
consumption was measured weekly and was determined by weighing the amount of 
food left in the cage and subtracted from the amount from the previous week.  Blood 
was collected bi-weekly in heparanized capillary tubes for glucose measurements using 
a glucometer and for serum determination of insulin and leptin (ELISA, Crystal Chem, 
Inc.).  Body composition was assessed in conscious mice by an NMR-based Minispec 
LF90II (Bruker Optics) analyzer (Figure 3.2).     
For analysis of reproductive function, female mice were checked daily from the 
time of weaning (at 28 days) for vaginal opening and thereafter for vaginal 
oestrogenization by cellular histology.  Mice were checked daily until a second estrous 
cycle was achieved, or for up to 61 days.     
Intraperitoneal Glucose (ipGTT ) and Insulin Tolerance Tests (ipITT) 
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For ipGTT, 13-week old mice were fasted overnight (16 hours), tails were nicked 
and blood glucose was measured using a glucometer.  Time was recorded at time 0 and 
then mice received (IP) one unit (0.001cc) (per gram of body weight) of a 30% dextrose 
solution per gram of body weight.  Blood glucose was sampled at 15, 30, 60 and 120 
minutes using the glucometer. 
 For ipITT, 14-week old mice were fasted for 4-5 hours, tails were nicked and 
blood glucose measured at time 0.  Insulin was diluted to 0.0025U/mL and each mouse 
received one unit per gram of body weight from the final dilution into their peritoneal 
cavity.  Blood glucose was sampled at 15, 30, 45, and 60 minutes using the glucometer.  
Insulin clearance was calculated by taking the average of the percent of initial glucose 
value (at time 0).     
Microdisections and tissue collection 
15-week-old male and female mice received an overdose of pentobarbital (150 
mg/kg, IP) and snout-anus length was measured with a micrometer.  Terminal blood 
(from trunk) was collected for future analysis of hormones in the serum.  Gross 
dissections were performed and tissues including hypothalamus, brown adipose tissue 
(BAT), liver, white adipose tissue (WAT), gonads, pancreas and muscle were collected.  
These tissue samples were weighed and either snap-frozen in dry ice or fixed in 10% 
formalin for further analysis of protein lysates and histology, respectively.  In male mice, 
specific brain regions were collected by microdissection.   
Perfusion and Immunohistochemistry (IHC)  
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For immunohistochemical analysis, 10 to 12-week old mice remained with food 
in the cage, and were treated with leptin (1mg/kg of body weight) or PBS for 2 hours 
and sacrificed between 9 a.m. and 12 p.m.   Perfusion and IHC procedures were 
performed essentially as described previously (90).  In brief, mice were deeply 
anesthetized with an overdose of pentobarbital (150 mg/kg, IP) and transcardially 
perfused with sterile PBS followed by 4% paraformaldehyde. Brains were removed, 
post-fixed and cryoprotected before sectioning into 30μm coronal slices, which were 
collected into 4 representative series and stored at -20˚C until further use.  For 
immunofluorescence, sections were pretreated in ice-cold methanol, 0.6% glycine and 
0.03% SDS, and then blocked with donkey serum and incubated in the primary antibody 
(rabbit-anti-pSTAT3 [1:500]). Detection of primary antibody was done by 
immunofluorescence with donkey anti-rabbit-Alexa 488 [1:200]. 
Statistical Analysis 
 Mean ± SEM and differences were analyzed by unpaired Student’s t-test to 
determine significant differences between groups (f/f versus +/+).  The difference 
between curves was analyzed by repeated measures ANOVA. Differences were accepted 
for p values ≤ 0.05, with an n value ≥ 10 for all. 
 
RESULTS 
Normal leptin-stimulated STAT3 in Lepr
f1077/f1077 
mice   
To facilitate the study of LepRb-Tyr1077 signaling to leptin action in vivo, we 
generated “knock-in” mice in which the Lepr was replaced by LeprF1077, where Phe 
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replaces Tyr1077 to abrogate phosphorylation of the site and block the majority of STAT5 
recruitment, as observed in cultured cells (83).  Using this approach, levels and patterns 
of pSTAT3-immunoreactivity (IR) expression for LeprF1077 are predicted to mimic those of 
wild-type mice (100;101).  To confirm that this was the case in f/f animals, we treated f/f 
and +/+ mice with leptin or PBS, and examined STAT3 phosphorylation (pSTAT3) in the 
basomedial hypothalamus by immunofluorescence.  As expected, both f/f and +/+ mice 
demonstrated similar patterns of leptin-activated pSTAT3-IR, consistent with the 
expression of functional LepRbF1077 in f/f mice (Figure 3.3).  
Lepr
f1077/f1077
 mice demonstrate modestly increased energy balance  
We initially examined the regulation of body weight in +/+ and f/f mice (of each 
sex) fed a normal chow (NC) or high fat (HF) diet.  While body weight in f/f males was 
similar to controls, analysis by repeated measures ANOVA revealed modestly increased 
body weight in female f/f animals (Figure 3.4).  Similarly, modest increases in body 
weight were observed in male and female animals subjected to a HF diet from 4-12 
weeks of age (Figure 3.5).   
On NC diet, food intake was detectably increased only in male f/f mice at the 
beginning of the study, but these small differences disappeared over the course of the 
study (Figure 3.4).  In HF diet-fed animals, however, food intake was detectably higher 
in f/f animals of both sexes compared to controls (Figure 3.5).  Thus, f/f animals on a HF 
diet display modestly increased in body weight and food intake, which suggests 
positive energy balance in f/f mice, although this effect is quite modest relative to 
db/db mice lacking LepRb or s/s mice lacking LepRb-Tyr1138STAT3 signaling.  
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Consistent with this notion, body adiposity (% fat) and fat pad weight were 
significantly increased in both male and female f/f mice on NC diet, while circulating 
leptin levels were only significantly higher in f/f females.  HF diet increased adiposity 
and fat pad weight in f/f mice of both sexes and both genotypes (although not to 
significant levels), while leptin levels did not change (Figure 3.6, Tables 3.1 and 3.2).  
While HF diet-fed f/f animals of both sexes trended to have higher adiposity and 
markers of adiposity, these differences were not significant; this may reflect the 
modest effect of the Leprb-Tyr1077 motif on adiposity relative to the effect of HF diet.  
Furthermore, lean mass was not different between f/f and +/+ mice of either sex or 
genotype on either diet (Figure 3.6).   
Improved glucose clearance in Lepr
f1077/f1077 
mice 
We found that glucose and insulin levels were similar in wild-type and mutant 
mice of either sex (Table 3.1).  Leptin contributes to glucose homeostasis in multiple 
ways: by modulating adiposity (and thus adiposity-dependent insulin resistance) and 
independently of body fat via an undefined pathway from the CNS to control hepatic 
glucose production, and potentially by the modulation of pancreatic insulin secretion.  
As we previously defined a Tyr985/Tyr1138-independent mechanism for the adiposity-
independent regulation of glucose homeostasis by leptin, we carefully examined 
parameters of glycemic control in f/f mice. 
Interestingly, while glucose clearance during an ipGTT in male f/f mice on NC diet 
was similar to controls, f/f females on NC diet displayed decreased glucose excursions 
(increased glucose clearance) following glucose challenge compared to controls.  
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Indeed, while ipGTT in HF-fed male f/f mice did not differ from controls, glucose 
excursions were dramatically lower in female HF-fed f/f animals compared to controls, 
especially at early time points (Figure 3.7).  This improved glucose tolerance in female 
f/f mice is not likely to be attributable to altered insulin sensitivity as insulin tolerance 
tests (ipITT) in f/f females were not different from controls for either diet (Figure 3.8). 
The improved glucose tolerance in female f/f animals independent of adiposity 
(increased adiposity would predict worsened glucose tolerance) suggests possible 
alterations in insulin secretion or hepatic glucose production in f/f females.  Also, we 
observed a significant increase in pancreatic weight in f/f females on both diets (Table 
3.2), which suggests a possible increase in β-cell mass and thus an increase in insulin 
secretion in f/f females.  These data suggest an important role for LepRb-Tyr1077
 in this 
effect.   
Impaired reproductive function in Lepr
f1077/f1077 
females  
Since important aspects of leptin action on reproductive function are mediated 
independently of Tyr985 and Tyr1138, we also examined the reproductive axis in female 
f/f mice since the energetic cost and thus leptin-dependence of reproduction is higher 
in females.  Estrous cycling was monitored daily by studying vaginal cellular histology in 
NC-fed females from 28 days to 61 days of age.  There was no significant difference on 
the time of vaginal opening (average of 31 days) or the time to the first estrous cycle 
(44 days) between f/f and +/+ females (Figure 3.9).  Interestingly, however, while the 
majority of +/+ mice had a second estrous cycle by 61 days of age (84%), only 42% of 
the f/f mice did.  Furthermore, the time between the first and the second estrous cycle 
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(E1 and E2) was significantly delayed in the f/f mice that underwent a second estrous (5 
± 0.4 days in +/+ versus 9 ± 2 days in f/f) (Figure 3.10).  Also, a trend to heavier ovaries 
was detected on f/f females on NC diet, and ovarian weight was significantly increased 
in female f/f mice on a HF diet compared to +/+ females (Table 3.2), which suggests 
that the observed reproductive defect in f/f females may also cause localized defects in 
the ovaries.  Thus, LepRb-Tyr1077 mediates an important component of leptin action on 
the reproductive axis.  
DISCUSSION 
Leptin-deficient ob/ob mice and LepRb-deficient db/db mice have provided great 
insight into the importance of leptin and LepRb signaling.  In order to understand the 
mechanisms by which LepRb mediates the physiological actions of leptin, we have 
previously examined the phenotype of mice mutant for LepRb-Tyr985 and LepRb-Tyr1138.  
Mice lacking LepRb-Tyr985 (l/l) are leaner and more sensitive to leptin than littermate 
controls, but otherwise normal.  In contrast, mice lacking LepRb-Tyr1138 (s/s) have 
increased body weight, adiposity and food intake- approaching but slightly less dramatic 
than in db/db mice.  Thus, while Tyr1138 is required for most leptin action on energy 
balance, Tyr1138-independent pathways presumably mediate at least some effects.  
Furthermore, while db/db animals are completely infertile, s/s females ovulate and bear 
normal-sized litters (although they fail to lactate following delivery); s/s animals also 
display improved glucose homeostasis in relation to db/db animals.  Thus, LepRb signals 
other than those emanating from Tyr985 and Tyr1138 must contribute to the control of 
65 
 
glucose homeostasis and reproduction, as well as to a minor component of energy 
balance. 
LepRb-Tyr1077 plays a minor role in the regulation of energy balance 
 
In this study, we explored the function of LepRb-Tyr1077 by using a novel mouse 
model with defective LepRb-Tyr1077 signaling (Lepr
f1077/f1077
); based upon phenotypes of 
mice with defective LepRb signaling, such as those lacking LepRb-Tyr985 and LepRb-
Tyr1138, we postulated minor defects in energy balance and predicted changes in 
reproduction and glucose homeostasis in the f/f mice.  Indeed, f/f animals exhibited 
increased adiposity on NC diet, as well as displayed increased body weight and food 
intake on a HF diet.  The increased adiposity of f/f animals on NC diet was modest 
compared to that of age-matched db/db and s/s mice, however, and minimal compared 
to the increase in adiposity observed with HF-feeding.  
Impaired reproduction and enhanced glucose tolerance in female Lepr
f1077/f1077
mice 
Female f/f mice entered puberty normally, as revealed by normal vaginal 
opening and first vaginal estrous, but exhibited absent or delayed estrous subsequently.  
Thus, the lack of LepRb-Tyr1077 signaling impairs the normal post-pubertal cycling and 
presumably ovulation in females.  These results reveal the importance of LepRb-Tyr1077 
to the permissive action of leptin on the reproductive axis.  Since leptin acts in the CNS 
to promote neuroendocrine reproductive function, this presumably reflects the 
importance of this signal within the CNS, but this will require further analysis. 
Although no differences were observed in glucose and insulin levels in ad libitum 
fed animals, female f/f mice displayed a pronounced increase in glucose clearance (in 
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ipGTT); this effect was more noticeable in mice fed a HF diet.  Interestingly, insulin 
tolerance during an ipITT was normal in female f/f animals, suggesting that increased 
glucose tolerance in f/f female mice is not due to increased insulin sensitivity.  This 
suggests that f/f females may display increased insulin secretion in the face of an acute 
glucose challenge, or may have other alterations in glucose production.  Given the 
increased weight of pancreata from f/f mice, we postulate that insulin secretion may be 
increased.  Indeed, a number of studies have suggested that leptin attenuates glucose-
stimulated insulin secretion and it is possible that Tyr1077 contributes to this effect.  We 
plan to perform glucose-stimulated-insulin-secretion (GSIS) as well as insulin clamp 
studies to address this issue.  We will also examine pancreatic histology to detect any 
possible differences in islet size or morphology.  Overall, these results suggest that 
LepRb-Tyr1077 is important for the regulation of glucose homeostasis by leptin.   
Downstream signaling by LepRb-Tyr1077  
Leptin treatment activates STAT5 in cultured cells and in vivo, and LepRb-Tyr1077 
mediates the majority of leptin-stimulated STAT5 activation in cultured cells.  While 
technical limitations have prevented us from examining leptin-stimulated STAT5 
activation in the hypothalamus of f/f mice, it is reasonable to believe that Tyr1077 
functions similarly to recruit STAT5 in vivo.  While the effect of mutating Tyr1077 on leptin 
action in f/f mice may be secondary to altered STAT5 signaling, a number of 
observations suggest caution regarding this conclusion.  Deletion of STAT5 in the CNS of 
Nestin-cre;Stat5fl mice results in modestly increased body weight and adiposity at young 
ages (150), similar to f/f mice, but without apparent defects in reproduction or 
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enhancements in glucose tolerance as observed in f/f mice.  Unfortunately, however, 
reproduction and glucose homeostasis were not carefully studied in the Nestin-
cre;Stat5fl mice and it is not possible to know whether alterations in these pathways 
exist.  The defect in energy balance (obesity) in older Nestin-cre;Stat5fl mice is much 
more pronounced than in our f/f mice, but it is not clear whether this difference reflects 
only differences in age, or also blockade of STAT5 signaling by other factors (such as 
GM-CSF) and the more widespread deletion of STAT5 in these mice than in just LepRb 
neurons.   
Also, some evidence suggests that leptin induces phosphorylation of some 
members of the insulin receptor substrate (IRS) protein family, leading to 
phosphorylation of PI3K (152).  Among other IRS proteins, IRS4 is highly expressed in 
many areas of the hypothalamus (153;154).  Mice lacking IRS4 display impaired 
reproduction, and slightly lower blood glucose concentration (both fed and fasted) while 
plasma insulin concentrations remain normal, and only modest defects in energy 
balance are found (155).  While some of the IRS4-null phenotype may reflect altered 
pituitary function, one study suggests that IRS4 may interact with LepRb via Tyr1077 
(156).  Although this study has many limitations, we must at least consider the 
possibility that LepRb-Tyr1077 may act in part via this pathway.   
Neurophysiological basis and neuroanatomical localization of Tyr1077 action 
The absence of STAT5 in the CNS (in Nestin-cre;Stat5fl mice) did not alter mRNA 
expression of some of leptin’s known targets in the ARC (i.e. POMC, AgRP, NPY) (150) 
suggesting that other genes (and possibly, other brain areas) must represent the key 
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transcriptional targets of STAT5 in the regulation of energy balance.  In fact, STAT5 
colocalizes with orexin (OX) neurons (which are cells devoid of LepRb) in the LHA in wild-
type mice, and Nestin-cre;Stat5fl mice exhibited mild dysregulation of OX in the LHA, 
suggesting that STAT5 may play a role in the regulation of these neurons.  In order to 
understand the neuronal populations potentially affected in f/f mice, it will be 
important to assess mRNA expression of these (POMC, AgRP, NPY, OX) and other 
neuropeptides, and the regulation of neuronal firing in the hypothalamus of f/f mice.  
 
FUTURE DIRECTIONS 
Our present results with the f/f mice reveal that LepRb-Tyr1077 contributes little 
to the regulation of body weight, but is important for the control of some aspects of 
glucose homeostasis and reproduction by leptin.  Many questions remained to be 
answered, however.  
So far, we have no reliable antibody to detect STAT5 phosphorylation in brain 
sections; therefore, we are currently testing if regulation of STAT5 is different in f/f mice 
by looking at STAT5 nuclear localization by immunohistochemistry (together with DAPI 
staining).  This would be crucial as we seek to determine if STAT5 activation is decreased 
in f/f mice, as we expect.  We also plan to study neuronal activation in these mutant 
mice by examining cFos- and pS6-IR, as LepRb-Tyr1077 might be important for the 
activation of some neurons (and possibly the mTORC1 pathway) in the basomedial 
hypothalamus.  Moreover, we will use IHC techniques to study other mechanisms via 
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pathways such as IRS/PI3K and determine if these signaling pathways are regulated 
differently in f/f mice.   
Given that we observed improved glucose tolerance in f/f females, it will be 
important to determine whether this effect is due to increased insulin production and 
secretion from the β-cells, or  if there are other signals from the hypothalamus that are 
controlling glucose transport to the liver independently of insulin.  We will thus subject 
13-week old f/f and +/+ female mice fed a HF diet to glucose-stimulated-insulin-
secretion (GSIS) studies, and insulin clamps.  GSIS analysis will help us determine if 
glucose clearance is due to an increased acute insulin secretion and insulin clamps will 
provide information on glucose production and uptake in the periphery.  
Female f/f mice had absent or delayed estrous cycling and to study this 
reproductive defect even further, we are currently monitoring estrous cycling in females 
on a HF diet to examine if an increase in fat affects cycling compared to a NC diet.  We 
also observed increased ovarian weight in f/f females compared to +/+ mice and we 
plan to study the histology of these ovaries in order to determine any differences in 
follicle morphology, the presence of cysts, increased adipose tissue and/or increased 
corpus luteum size.  Also, we want to assess if stimulation of estrous could be achieved 
in young f/f mice with gonadotropin treatment, which would help dissect if the 
phenotype observed is due to a direct impact at the ovarian level (independent of the 
hypothalamic-pituitary-adrenal (HPA) axis).  Furthermore, we will study the potential 
defects in the HPA axis of f/f mice by examining LH secretion in ovariectomized mice and 
determine leptin-stimulated LH secretion during the fasted and fed states.   
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 While db/db mice exhibit essentially complete blockade of the reproductive axis, 
both s/s and f/f animals display partial reproductive function.  What then are the 
contributions of Tyr1138 and Tyr1077? One important variable in the s/s mice is their 
other endocrine alterations, including hypercorticosteronemia and hypothyroidism- 
both which are likely to contribute to decreased fertility.  It is also possible that the 
disruption of a portion of STAT5 signaling by Tyr1138 in these s/s animals blunts 
reproductive function.  
The extension of this study will be accomplished by determining the phenotype 
of mice containing a double mutation on LepRb (Lepr
f1077/s1138
mice) which would help 
elucidate and clarify many aspects of LepRb-dependent signaling that still remain poorly 
defined, specifically via LepRbSTAT5 signaling.  Also, a mouse model lacking STAT5 in 
all LepRb-expressing neurons is currently being developed and studied in the Myers 
laboratory (LepRb-cre;Stat5fl mice).  This novel mouse model will help examine the 
specific role of STAT5 to the overall leptin action in vivo, including in the regulation of 
reproduction and glucose homeostasis.   
 
ACKNOWLEDGEMENTS 
We thank Yusong Gong for the generation of the leprF1077 construct and targeting 
and screening of mice ES cells in collaboration with the University of Michigan 
Transgenic Animal Model Core.  Thanks also to Justin C. Jones for the help with breeding 
and genotyping during the initial stages of the study of the Lepr
f1077/f1077
 mice.  We are 
very thankful to Dr. Natinder Saini and Zhixiao Zhang for all their help during the 
71 
 
phenotypical analysis of Lepr
f1077/f1077
 mice.  We thank Dr. Nathan Qi, Katie Gee and 
Nathan Kanner for their expertise and help during metabolic assessment of mice at the 


























Figure 3.1: Targeting strategy and deletion of “neo” cassette in LepRbf1077/f1077 mice 
Diagram of gene-targeting strategy to replace Lepr with LeprF1077, where Phe replaces 
Tyr1077 to abrogate phosphorylation of the site. In summary, targeted 129Sv embryonic 
stem (ES) cell clones were used to produce chimeric animals, which were crossed with 
C57Bl/6J mice to generate heterozygous leprf1077/+ (f/+) “knock-in” F1 mice expressing 
LepRbF1077 from the genomic context of endogenous LepRb.  Heterozygous f/+ mice were 
crossed with B6.FVB-Tg(EIIa-cre)C5379Lmgd/J mice to remove the “floxed” neomycin (neo) 
cassette found in the original targeting vector and used for screening purposes during the 


















Figure 3.2: Phenotypical analysis of LepRbf1077/f1077 mice 
Mice were single housed with ad libitum access to food and water.  For measurement of the 
phenotypic parameters, male and female mice were weighed weekly beginning at 4-weeks to 
12-weeks of age.  Food consumption was measured weekly and blood was collected bi-
weekly for glucose measurements and for serum determination of insulin and leptin. For 
analysis of reproductive function, female mice were checked daily from the time of weaning 
(at 28 days) for vaginal opening and thereafter for vaginal oestrogenization by cellular 
histology. After 12-weeks, mice were subjected to glucose tolerance tests (GTT) and insulin 
tolerance tests (ITT). After recovery, body composition was assessed in conscious mice by an 
NMR-based Minispec analyzer. Finally, mice were dissected, tissues were collected and 




















Figure 3.3: Normal leptin-stimulated pSTAT3-IR in LepRbf1077/f1077 
mice 
To confirm that the levels and patterns of pSTAT3-IR expression 
for LeprF1077 mimic those of wild-type mice, we treated f/f and 
+/+ mice with leptin (5mg/kg) or PBS for 2 h, and examined 
STAT3 phosphorylation (pSTAT3) in the basomedial 
hypothalamus by immunofluorescence.  As expected, both f/f 
and +/+ mice demonstrated similar patterns of leptin-activated 
pSTAT3-IR, consistent with the expression of functional 
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Figure 3.4: Modest increase in body weight and food intake in LepRbf1077/f1077 mice (NC diet) 
Mice were fed a normal chow (NC) throughout the study and body weight and food intake 
measured from 4-12 weeks of age. Body weight was similar to controls in males and food intake 
was only significantly different during the first two weeks of the study (smaller graph).  Body 
weight was modestly increased in female f/f mice, while food intake remained unchanged. 
Significant differences were analyzed by Student’s T-test at each time point (* p ≤ 0.05) and 
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Figure 3.5: Modest increase in body weight and food intake in LepRbf1077/f1077 mice (HF diet) 
Mice were fed a high fat (HF) diet (45 % fat) throughout the study and body weight and food 
intake measured from 4-12 weeks of age. We detected a modest increase in body weight in 
male and female f/f mice and food intake was detectably higher in f/f animals of both sexes 
compared to +/+ controls. Significant differences were analyzed by Student’s T-test at each time 
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Figure 3.6: LepRbf1077/f1077 mice present mild increase in body adiposity and no changes in lean 
mass   
Mutant (f/f) and wild-type (+/+) mice were fed a normal chow (NC) or a high fat (HF) diet from 4 to 
12-weeks of age. Body composition of 15-week old mice was determined and revealed that fat 
mass was significantly increased in f/f male and female mice on a NC diet. However, although mice 
on HF diet trended to have higher adiposity, these differences were not significant. Lean mass 
remained normal in mice for all the groups. Significant differences were analyzed by Student’s T-
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Figure 3.7: LepRbf1077/f1077 female mice have improved glucose clearance 
Mice were subjected to an intraperitoneal glucose tolerance test (ipGTT) at 13-weeks of 
age. While glucose clearance in male mice on NC diet was similar to controls (+/+), female 
f/f mice on ND diet had increased glucose clearance. These glucose excursions were 
dramatically decreased in female f/f mice fed a HF-diet at early time points (15 and 30 
minutes following a glucose challenge) as demonstrated in the ipGTT curve and 
determination of the area under the curve (AUC). Significant differences were analyzed by 
Student’s T-test at each time point (* p ≤ 0.05)  or by repeated measures ANOVA (‡ p= 
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Figure 3.8: Normal insulin tolerance in LepRbf1077/f1077 mice  
Mice were subjected to an intraperitoneal insulin tolerance test (ipITT) at 14-weeks of age. 
Insulin tolerance was determined by calculating the percent of initial glucose value. There 
were no significant differences detected in f/f animals of sex or diet, compared +/+ controls 
(with the exception of male mice fed a HF diet, which showed a slight insulin resistance at 
15 minutes). Significant differences were analyzed by Student’s T-test at each time point (* 

























































Figure 3.9: LepRbf1077/f1077 female mice have normal onset of puberty 
Vaginal opening (VO) and vaginal estrous (VE) was checked daily in f/f 
and +/+ female mice from 28 days to 61 days of age. There was no 
difference on the time of vaginal opening or the time (average of 31 
days) to the first estrous cycle (average of 44 days) in f/f mice and 































































Figure 3.10: Impaired estrous cycling in LepRbf1077/f1077 females 
Vaginal opening and vaginal estrous was checked daily in f/f and +/+ female mice from 28 
days to 61 days of age (or up to a second estrous cycle was achieved). While only 16% of 
+/+ mice did not have a second estrous cycle, 42% of f/f never underwent a second cycle. 
Also, the time between the first and the second estrous cycle was significantly delayed in 
the f/f mice that underwent a second estrous cycle. Significant differences were analyzed 

















NC Males  Females 
 +/+ f/f  +/+ f/f 
Glucose 6.9 ± .22 6.8 ± .20  6.0 ± .20 6.0 ± .20 
Leptin 2.37 ± .39 2.92 ± .36  1.14 ± .10 1.64 ± .29 * 
Insulin 1.89 ± .26 2.32 ± .35  1.14 ± .12 .95 ± .10 
 
 
HFD Males  Females 
 +/+ f/f  +/+ f/f 
Glucose 6.8 ± .19 7.2 ± .30  6.5 ± .20 6.7 ± .20 
Leptin 7.07 ± .98 11.07 ± 2.4  5.97 ± 1.29 4.89 ± .77 





Table 3.1: Glucose, leptin and insulin levels in LepRbf1077/f1077 mice on NC- and 
HF- diets 
Fed glucose levels for male and female f/f and +/+ mice on normal chow (NC) and 
high fat (HF) diet. Leptin and insulin concentrations were determined by ELISA 
from serum samples. All measurements from mice at 12-weeks of age, values ± 




NC Males  Females 
 +/+ f/f  +/+ f/f 
S/A  92.2 ± .717 91.7 ± .498  88.2 ± .565 87.8 ± .717 
Liver .854 ± .025 .876 ± .021  .754 ± .020 .784 ± .025 
BAT .057 ± .003 .056 ± .002  0.043 ± .002 .046 ± .003 
WAT .400 ± .023 .503 ± .035 *  .142 ± .013 .293 ± .041 * 
Gonads .239 ± .010 .260 ± .010  .022 ± .001 .026 ± .002 † 
Pancreas .444 ± .022 .476 ± .021  .346 ± .009  .397 ± .027 * 
Spleen .087 ± .005 .079 ± .003  .1050 ± .006 .0938 ± .004 
Muscle .138 ± .004 .131 ± .002  .109 ± .002 .106 ± .003 
 
HFD Males  Females 
 +/+ f/f  +/+ f/f 
S/A  91.1 ± .850 91.5 ± 1.360  87.8 ± .710 87.5 ± .746 
Brain .457 ± .007 .463 ± .005  .461 ± .005 .460 ± .005 
Liver .695 ± .030 .785 ±.049  .554 ± .020 .580 ± .025 
BAT .087 ± .006 .082 ± .010  0.052 ± .003 .057 ± .006 
WAT 1.074 ± .105 1.365 ± .183  .300 ± .054 .365 ± .066 
Gonads .233 ± .007 .252 ± .014  .0182 ± .001 .0215 ± .001 * 
Pancreas .531 ± .036 .600 ± .049  .333 ± .024 .425 ± .034 * 
Spleen .092 ± .006 .086 ± .003  .127 ± .025 .099 ± .005 






Table 3.2: Physiological parameters studied in LepRbf1077/f1077 mice  
At the end of the study, mice were sacrificed and tissues collected, weighted and 
harvested. S/A length was also measured. All measurements from mice at 15-





LEPTIN-DEPENDENT SIGNALING PATHWAYS REVISITED 
 
 
SUMMARY AND CONCLUSIONS 
The study of energy homeostasis and leptin neurophysiology   
For years, scientists have struggled to understand the pathways regulating body 
weight and energy homeostasis.  The discovery of leptin advanced our understanding of 
energy balance tremendously because it provided a mechanism to coordinate energy 
intake, energy storage and energy expenditure in mammals.  Leptin is a peptide 
hormone secreted in rough proportions to body adiposity, which acts on brain LepRb-
expressing neurons to inhibit appetite and increase energy utilization.  While leptin acts 
in many locations throughout the brain, in the ARC, leptin induces the activation and 
release of proopiomelanocortin (POMC) while inhibiting neuronal activation of Agouti 
related peptide (AgRP) and Neuropeptide-Y (NPY) cells in the arcuate nucleus (ARC) of 
the hypothalamus.  Also in the ARC, there are populations of neurons that express 
kisspeptin, which appears to express LepRb and likely project to GnRH-containing 
neurons to induce the release of gonadotropin-releasing hormone and control 
reproduction.  However, not all leptin’s effects are mediated by neurons located in the 
ARC, many other neuronal populations and brain regions are also important in 
mediating leptin action.  In the ventromedial hypothalamus (VMH), steroidogenic factor-
1 (SF-1)-expressing neurons are required for normal body weight homeostasis (80).  The 
ventral premammillary nucleus (PMv) is another site that contains a large population of 
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LepRb neurons and is well known to regulate sexual and aggressive behaviors (157;158).   
Also, areas within the mesolimbic dopamine system, such as the ventral tegmental area 
(VTA) and the lateral hypothalamic area (LHA), contain LepRb-expressing neurons that 
seem to be important for the control of motivational processes (159).  Thus, leptin is not 
only an adiposity signal but also a signal that plays roles in physiological functions such 
as growth, reproduction, glucose control, and immune response; and its action is not 
localized to one specific brain center but many regions are involved in the regulation of 
these leptin-dependent functions.   
Leptin receptor-dependent signaling pathways   
Leptin acts through a cytokine receptor, LepRb, which is expressed in areas of 
the hypothalamus and brain regions that respond to and effect energy balance.  Upon 
LepRb activation, Jak2 autophosphorylates and activates, promoting the 
phosphorylation of downstream targets, including: LepRb-Tyr985, Tyr1077 and Tyr1138.  
Based on cell culture studies, we know that Tyr985 is responsible for the recruitment of 
the SH2-containing tyrosine phosphatase-2 (SHP2) to mediate the first step in the 
activation of the extracellular signal-regulated kinase (ERK) cascade (83-85).  Also, 
phosphorylated Tyr985 binds the suppressor of cytokine signaling-3 (SOCS3), which acts 
as a negative regulator of LepRb signaling (86).  Many different studies have shown that 
Tyr1138 recruits the signal transducer and activator of transcription-3 (STAT3), which 
mediates the regulation of gene expression, including SOCS3 (84;87). The 
phosphorylation of Tyr1077 promotes the recruitment, tyrosine phosphorylation, and 
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transcriptional activation of STAT5, although Tyr1138 may also play a minor role in the 
regulation of STAT5 phosphorylation (83;91).   
The knowledge of the pathways controlled by LepRb is based on both in vitro 
and in vivo evidence, and studies have shown that leptin controls many pathways other 
than those controlled directly by LepRb-Tyr residues.  Among the  indicators of cellular 
energy status implicated in the regulation of leptin-dependent circuits are the AMP-
dependent protein kinase (AMPK, which is activated in response to increased AMP/ATP 
ratios, among other signals of decreased cellular energy) (95;116), and the mammalian 
target of rapamycin (mTOR).   
In vitro studies are a great tool to study these aforementioned pathways but 
there is some difficulty in dissecting these signals by LepRb because of the inability to 
observe their regulation in cultured cells without overexpressing multiple signaling 
proteins that likely result in the non-specific activation of some signaling pathways.  
Additionally, the opposite regulation of some signals by leptin in distinct types of LepRb 
neurons complicates the analysis of their regulation in vivo.  Thus, in order to 
circumvent these limitations, we have developed different mouse models of LepRb 
deficiency to study the specific contribution of individual signaling pathways to the 
overall physiological action of leptin.   
The study of leptin-dependent functions in vivo 
The information obtained from studying different mouse models is crucial to 
help explain regional regulation as well as the contribution of specific signaling 
pathways (from Jak2, Tyr residues in LepRb and others such as AMPK, mTOR, PI3K, etc).  
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Among the most important mouse models that made the studies mentioned in this 
dissertation possible, ob/ob and db/db mice are fundamental models mainly because 
the increased leptin sensitivity in ob/ob mice allows for the immediate detection of 
activated pathways by leptin, and lack of LepRb in db/db mice allows an easy 
comparison to other mouse models of LepRb-deficiency.   
Mouse models developed in the Myers laboratory in the past years have 
provided valuable information and enhanced our understanding of LepRb signaling.  
“Knock-in” mice expressing mutant LepRb molecules from the genomic context of 
endogenous LepR have been generated for different LepRb motifs.  Phenotypical 
analysis of mice expressing truncated LepRb containing the binding site for Jak2 but 
devoid of other LepRb intracellular sequences (LepRb∆/LepRb∆ mice) demonstrated a 
phenotype that closely resembles db/db mice in terms of energy homeostasis, 
neuroendocrine and immune function as well as the regulation of the ARC, but 
demonstrated modest improvements in glucose homeostasis.  Thus, the fact that Jak2-
autonomous LepRb signals failed to mediate leptin action suggests that leptin action is 
primarily mediated by pathways controlled by the phosphorylation of tyrosine residues 
within LepRb (105).  Studies in mice with mutated LepRb-Tyr1138 (s/s) have proven that 
this Tyr1138 recruits STAT3 and plays a major role in regulating body weight and 
adiposity.  The analysis of  s/s mice also suggested that there are LepRb1138STAT3 
independent signals that control reproduction and glucose homeostasis, given that s/s 
mice have an improved reproductive response, and greatly improved glycemic control 
compared to db/db animals.   
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On the other hand, LepRb-Tyr985 appears to play an important role in the 
attenuation of LepRb signaling (possibly via SOCS3) in vivo as well as in cultured cells: 
mice containing a replacement of Tyr985 (Lepr
l985/l985 or l/l), have decreased body weight 
and increased leptin sensitivity but are otherwise normal compared to +/+ controls 
(Table 4.1).  However, the contributions of other LepRb-dependent and -independent 
signaling pathways should be considered as we seek to determine how leptin controls 
physiological functions via LepRb. 
In this dissertation, we have extended our understanding of the mechanisms 
that contribute to the regulation of hypothalamic signals and physiological control by 
LepRb.  We initially studied the regulation of the mammalian target of rapamycin 
complex-1 (mTORC1) pathway in the basomedial hypothalamus by examining the 
regulation of mTORC1 by nutritional and metabolic cues such as leptin, LepRb signals, 
insulin, ghrelin, and fasting, and by investigating the specific site (neuronal populations) 
of mTORC1 activation in the arcuate nucleus (ARC) in response to the above cues.  We 
also investigated the role of LepRb-Tyr1077 in vivo by examining leptin action and the 
physiologic phenotype of mice with replacement of Tyr1077 (Lepr
f1077/f1077 or f/f mice).   
Leptin-independent regulation of mTORC1 in vivo   
  Using an immunohistochemistry methodology to detect pS6-IR, we explored the 
regulation of mTORC1 by leptin and nutritional manipulation (i.e. fasting) in the ARC and 
confirmed the expected enhancement of mTORC1 signaling upon leptin treatment.  
However, these studies also revealed increased mTORC1 activity in LepRb and AgRP-
expressing neurons in the MB-ARC by fasting and leptin-deficiency.  In contrast, fasting 
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and leptin deficiency decrease mTORC1 activity in the VMH.  Our data reveal the IHC 
detection of pS6-IR in the MB-ARC to be largely dependent upon the major mTORC1 
mediator, S6K1, and to be entirely dependent upon mTORC1 itself. 
We explored the signaling mechanisms by which LepRb might modulate the 
accumulation of pS6-IR in the MB-ARC by studying mTORC1 regulation in l/l and s/s 
mice, and found that neither Tyr985 nor Tyr1138 participate in the regulation of MB-ARC 
pS6-IR under conditions of endogenous leptin. 
Our most interesting finding was the mechanism by which fasting and leptin-
deficiency mediate mTORC1 activation.  We found that mTORC1 activation in the ARC is 
indirect, via the regulation of neural activity.  This conclusion was supported by the 
correlation between the induction of pS6-IR in the MB-ARC under nutritional conditions 
and genetic environments in which orexigenic (AgRP) neurons are activated (140;160), 
and by the induction of pS6-IR primarily in neurons that also demonstrate evidence of 
activation (c-Fos-IR) both in the MB-ARC and in the oppositely-regulated VMH.  Also, 
ghrelin, which acutely depolarizes the orexigenic neurons of the MB-ARC (134), 
promotes pS6-IR and c-Fos-IR in the MB-ARC.  Since leptin depolarizes and promotes the 
firing of some neurons within the MB-ARC (140;142), it is possible that the previously 
reported activation of mTORC1 during acute leptin treatment also takes place secondary 
to changes in neuronal activity.  Another reasonable possibility is that leptin might 
promote mTORC1 signaling via the induction of PI3K, which is an important upstream 
activator of mTORC1 (118-120).  Indeed, the observation that insulin (whose major 
signaling output is via PI3K (143)) promotes pS6-IR in the mediobasal hypothalamus 
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without increasing c-Fos-IR suggests that robust PI3K activation in the hypothalamus 
stimulates mTORC1, as in cultured cells.   
Some studies suggest that mTORC1 is required to control leptin-induced anorexia 
during re-feeding conditions.  However, deletion of the mTORC1 inhibitor TSC1 from 
POMC neurons (in Pomc-Tsc1cKO mice) (161) suggest that hypothalamic mTORC1 
mediates an orexigenic signal, since these mice with mTORC1 activation demonstrate 
pronounced dysregulation of POMC cells and hyperphagic obesity.  Overall, we believe 
that neuronal activation is the main regulator of mTORC1 activity in the hypothalamus 
in response to metabolic perturbations.  Leptin and nutritional cues do not modulate 
hypothalamic mTORC1 activity in a uniform manner, but rather control mTORC1 via 
multiple pathways and, in many cases, in opposite directions in different cell types and 
brain regions, and the function of mTORC1 is likely to vary from cell type to cell type. 
LepRb-Tyr1077 contributes to the regulation of reproduction and glucose homeostasis 
by leptin   
 
In order to understand the mechanisms by which LepRb mediates the 
physiological actions of leptin, we have previously examined the phenotype of mice 
mutant for LepRb-Tyr985 and LepRb-Tyr1138.  In this study, we explored the function of 
LepRb-Tyr1077 by using a novel mouse model with defective LepRb-Tyr1077 signaling 
(Lepr
f1077/f1077
).  Based on phenotypes of mice lacking LepRb-Tyr985 and LepRb-Tyr1138, we 
postulated minor defects in energy balance and substantial changes in reproduction and 
glucose homeostasis in these mice.  Indeed, f/f animals displayed modest increases in 
body weight and food intake, especially on a HF diet, as well as exhibiting increased 
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measures of adiposity on NC diet.  The increased adiposity of f/f animals was mild 
compared to that of db/db and s/s mice, however, and small compared to the increase 
in adiposity observed with HF-feeding, so that differences in adiposity were not 
statistically significant on HF diet.   
Interestingly, female f/f mice entered puberty normally, but exhibited absent or 
delayed estrous cycling.  Thus, the lack of LepRb-Tyr1077 signaling impairs the normal 
post-pubertal cycling and presumably ovulation in females.  These results reveal the 
importance of LepRb-Tyr1077 to the permissive action of leptin on the reproductive axis.  
Since leptin acts in the CNS to promote neuroendocrine reproductive function, this 
significant finding presumably reflects the importance of Tyr1077-mediated signaling 
within the CNS. 
Although no differences were observed in glucose and insulin levels in ad libitum 
fed animals, female f/f mice displayed a pronounced increase in glucose clearance 
together with normal insulin tolerance.  Apparently, f/f females may display increased 
insulin secretion in the face of an acute glucose challenge, or may have other alterations 
in glucose production.  Given the increased weight of pancreata from f/f mice, we 
postulate that insulin secretion may be increased.  Overall, these results suggest that 
LepRb-Tyr1077 is important for the regulation of glucose homeostasis by leptin.   
Leptin treatment activates STAT5 in cultured cells and in vivo, and LepRb-Tyr1077 
mediates the majority of leptin-stimulated STAT5 activation in cultured cells.  While 
technical limitations have prevented us from examining leptin-stimulated STAT5 
activation in the hypothalamus of f/f mice, it is reasonable to believe that Tyr1077 
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functions similarly to recruit STAT5 in vivo.  In fact, deletion of STAT5 in the CNS of 
Nestin-cre;Stat5fl mice results in modestly increased body weight and adiposity at young 
ages, similar to f/f mice, but without apparent defects in reproduction or enhancements 
in glucose tolerance as observed in f/f mice.  Unfortunately, reproduction and glucose 
homeostasis were not carefully studied in the Nestin-cre;Stat5fl mice and it is not 
possible to know whether alterations if these pathways exist.  The obesity observed in 
older Nestin-cre;Stat5fl mice is much more pronounced than in our f/f mice, but it is not 
clear whether this difference reflects only differences in age, or also blockade of STAT5 
signaling by other factors and the more widespread deletion of STAT5 in these mice.  
Also, the possibility of leptin inducing phosphorylation of IRS proteins and PI3K together 
with some evidence that suggests that IRS4 may interact with LepRb via Tyr1077 (and the 
phenotypical similarity between IRS4-null mice and f/f mice) dictates that we must at 
least consider the possibility that LepRb-Tyr1077 may act in part via the IRS4-PI3K 
pathway.  These and other LepRb-Tyr1077–dependent pathways are worth examining, as 
well as the hypothalamic neuronal regulation in order to understand the specific 
neuronal populations potentially affected in f/f mice.  
Importance of the study and clinical applications   
In this thesis, we have identified the mechanisms of hypothalamic mTORC1 
regulation and demonstrated its place in signaling downstream of neuronal activation.  
This mTORC1 signal is crucial for energy balance (94;161).  Additionally, we identified a 




It is important to understand the specific pathways that regulate different 
physiological functions via LepRb, such as energy balance, because dissecting these 
specific signaling pathways could provide possible targets for the development of 
pharmacological therapies for the treatment of obesity and diabetes.  However, leptin 
also regulates some aspects of reproduction and glucose homeostasis, and examining 
the mediators involved in these signaling pathways could provide a basis to better 
understand, and possibly, treat conditions linking metabolism to reproductive defects 
such as polycystic ovarian syndrome (PCOS), ovulatory infertility, menstrual irregularity 
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Figure 4.1: Proposed model for the mechanisms of LepRb signaling in vivo 
LepRb activates Jak2 to initiate tyrosine-phosphorylation-dependent signal transduction 
pathways. In cultured cells, Tyr985 activates the SHP2/ERK cascade.  Activation of Tyr1077 
and Tyr1138 induces phosphorylation of STAT5 and STAT3, respectively (although Tyr1138 
may also mediate a minor component of STAT5 phosphorylation), stimulating the 
translocation of STAT3 and STAT5 to the nucleus. Although the pertinent transcriptional 
targets of STAT5 remain unknown, several STAT3 transcriptional targets have been 
identified, including SOCS3 (which inhibits LepRb signaling). Tyr1077 seems to play an 
important role in the regulation of reproduction and glucose homeostasis and/or insulin 
secretion (presumably via STAT5). We do not yet fully understand the mechanisms by 
which LepRb activates other signals, such as IRS and PI3K in the hypothalamus, but we 
now know that cell depolarization activates mTORC1, at least in some cell types (Adapted 
from Villanueva, E, and Myers, MG, Leptin receptor signaling and the regulation of 
























      
 +/+ db/db s/s l/l f/f 
  Wild-type No LepRb No Tyr-1138 No Tyr-985 No Tyr-1077 
Body Weight ↔ ↑↑↑ ↑↑ ↓♀ ↑ 
Food Intake ↔ ↑↑ ↑↑ ↔ ↑♀ 
Fat Mass ↔ ↑↑↑ ↑↑ ↔ ↑ 
Lean Mass ↔ ↑ ↑↑ ↔ ↔ 
Linear Length ↔ ↓ ↑ ↔ ↔ 
Glucose ↔ ↑↑↑ ↑↑ ↔ ↔ 
Leptin ↔ ↑↑↑ ↑↑ ↓ ↑ 
Insulin ↔ ↑↑ ↑↑ ↓♀ ↔ 
Glucocorticoids ↔ ↑↑ ↑↑ ND ND 















Table 4.1: Comparison between different models with LepRb defects 
Phenotypical parameters studied in different mouse models with LepRb defects. Note 
the pronounced increased in adiposity of db/db and s/s mice, which is very mild 
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